{
  "meta": {
    "id": "test11",
    "title": "Neoplasia",
    "category": "Subject Wise / Mixed"
  },
  "questions": [
    {
      "text": "An elderly female with mediastinal mass undergoes a microscopic examination showing red cell aplasia. What is the likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Bronchogenic carcinoma",
          "correct": false
        },
        {
          "label": "B",
          "text": "Thymoma",
          "correct": true
        },
        {
          "label": "C",
          "text": "Non-Hodgkin lymphoma",
          "correct": false
        },
        {
          "label": "D",
          "text": "Squamous cell carcinoma",
          "correct": false
        }
      ],
      "correct_answer": "B. Thymoma",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Thymoma</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Bronchogenic carcinoma: Bronchogenic carcinoma refers to a type of lung cancer originating from the bronchi . Although it can present with a mediastinal mass , it is not typically associated with pure red cell aplasia , which is a reduction in the production of red blood cells .</li><li>\u2022 Option A. Bronchogenic carcinoma:</li><li>\u2022 type of lung cancer</li><li>\u2022 bronchi</li><li>\u2022 mediastinal mass</li><li>\u2022 not</li><li>\u2022 pure red cell aplasia</li><li>\u2022 reduction in the production of red blood cells</li><li>\u2022 Option C. Non-Hodgkin lymphoma: Non-Hodgkin lymphoma is a diverse group of blood malignancies that includes any kind of lymphoma except Hodgkin's lymphomas . Types of Non-Hodgkin lymphoma can involve the mediastinum but are not typically associated with pure red cell aplasia.</li><li>\u2022 Option C. Non-Hodgkin lymphoma:</li><li>\u2022 diverse group of blood malignancies</li><li>\u2022 lymphoma</li><li>\u2022 Hodgkin's lymphomas</li><li>\u2022 Types of Non-Hodgkin lymphoma</li><li>\u2022 mediastinum</li><li>\u2022 not typically</li><li>\u2022 pure red cell aplasia.</li><li>\u2022 Option D. Squamous cell carcinoma: Squamous cell carcinoma can arise in various organs, including the lungs, but is not commonly associated with pure red cell aplasia or mediastinal masses unless it is metastatic from another primary location .</li><li>\u2022 Option D. Squamous cell carcinoma:</li><li>\u2022 Squamous cell carcinoma</li><li>\u2022 organs,</li><li>\u2022 not</li><li>\u2022 pure red cell aplasia or mediastinal masses</li><li>\u2022 metastatic from</li><li>\u2022 primary location</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Thymomas are mediastinal tumors that may be associated with paraneoplastic syndromes, including pure red cell aplasia, which is characterized by a selective decrease in red blood cell precursors.</li><li>\u27a4 Thymomas</li><li>\u27a4 mediastinal tumors</li><li>\u27a4 paraneoplastic syndromes,</li><li>\u27a4 pure red cell aplasia,</li><li>\u27a4 decrease</li><li>\u27a4 red blood cell precursors.</li><li>\u27a4 Ref : Robbins 10th/e p493</li><li>\u27a4 Ref</li><li>\u27a4 : Robbins 10th/e p493</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4bf00069",
      "audio": ""
    },
    {
      "text": "Match the following genes correctly with their tumors:",
      "options": [
        {
          "label": "A",
          "text": "A-2, B-3, C-4, D-1",
          "correct": false
        },
        {
          "label": "B",
          "text": "A-3, B-2, C-1, D-4",
          "correct": false
        },
        {
          "label": "C",
          "text": "A-4, B-3, C-2, D-1",
          "correct": false
        },
        {
          "label": "D",
          "text": "A-2, B-1, C-4, D-3",
          "correct": true
        }
      ],
      "correct_answer": "D. A-2, B-1, C-4, D-3",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/08/screenshot-2024-02-08-150523.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/18/screenshot-2024-06-18-100314.JPG"
      ],
      "explanation": "<p><strong>Ans. D) A-2, B-1, C-4, D-3</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 C- myc is associated with Burkitt\u2019s lymphoma (Ref: Robbins\u2026316) PLAG 1 is associated with pleomorphic adenoma (Ref: Robbins\u2026748) N myc is associated with neuroblastoma (Ref: Robbins\u2026289) Rb is associated with retinoblastoma (Ref: Robbins\u2026147)</li><li>\u27a4 C- myc is associated with Burkitt\u2019s lymphoma (Ref: Robbins\u2026316)</li><li>\u27a4 C- myc</li><li>\u27a4 Burkitt\u2019s lymphoma</li><li>\u27a4 PLAG 1 is associated with pleomorphic adenoma (Ref: Robbins\u2026748)</li><li>\u27a4 PLAG 1</li><li>\u27a4 pleomorphic adenoma</li><li>\u27a4 N myc is associated with neuroblastoma (Ref: Robbins\u2026289)</li><li>\u27a4 N myc</li><li>\u27a4 neuroblastoma</li><li>\u27a4 Rb is associated with retinoblastoma (Ref: Robbins\u2026147)</li><li>\u27a4 Rb</li><li>\u27a4 retinoblastoma</li><li>\u27a4 Ref : Robbins 10 th / 147, 289, 316, 748</li><li>\u27a4 Ref</li><li>\u27a4 : Robbins 10 th / 147, 289, 316, 748</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7e2d1d55",
      "audio": ""
    },
    {
      "text": "A 31-year-old female has fecal blood identified during a physical examination. A colonoscopy reveals an ulcerated mass in her proximal rectum. In the past, she was operated and treated for a ductal carcinoma of her left breast and a malignant thyroid tumor. Of the following, what is the most likely mutation if she is diagnosed with Cowden\u2019s syndrome?",
      "options": [
        {
          "label": "A",
          "text": "Mutation of the PTEN gene",
          "correct": true
        },
        {
          "label": "B",
          "text": "Mutation of the CDKN2 gene",
          "correct": false
        },
        {
          "label": "C",
          "text": "Mutation of RB gene",
          "correct": false
        },
        {
          "label": "D",
          "text": "Mutation of the WT gene",
          "correct": false
        }
      ],
      "correct_answer": "A. Mutation of the PTEN gene",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Mutation of the PTEN gene</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Mutations of CDKN2 are associated with malignant melanoma</li><li>\u2022 Option B.</li><li>\u2022 CDKN2</li><li>\u2022 malignant melanoma</li><li>\u2022 Option C. RB with retinoblastoma.</li><li>\u2022 Option C.</li><li>\u2022 RB</li><li>\u2022 retinoblastoma.</li><li>\u2022 Option D. WT with Wilms tumor</li><li>\u2022 Option D.</li><li>\u2022 WT</li><li>\u2022 Wilms tumor</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Patients with Cowdens syndrome have mutation of the PTEN gene .</li><li>\u2022 Patients</li><li>\u2022 Cowdens syndrome</li><li>\u2022 mutation of the PTEN gene</li><li>\u2022 Ref : Robbins and Cotran pathologic basis of disease 10th edition page:292 table: 7.7</li><li>\u2022 Ref</li><li>\u2022 : Robbins and Cotran pathologic basis of disease 10th edition page:292 table: 7.7</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9dd6f9f2",
      "audio": ""
    },
    {
      "text": "A patient with Burkitt lymphoma presents with lethargy, weakness, and oliguria after receiving the first cycle of chemotherapy. Laboratory tests reveal abnormalities consistent with tumor lysis syndrome (TLS). Which of the following laboratory findings is LEAST likely to be associated with this condition?",
      "options": [
        {
          "label": "A",
          "text": "Hyperuricemia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hyperkalemia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Hyperphosphatemia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Hypercalcemia",
          "correct": true
        }
      ],
      "correct_answer": "D. Hypercalcemia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Hypercalcemia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanations</li><li>\u2022 Option A. Hyperuricemia is typically seen in TLS due to the increased turnover of nucleic acids from rapid cell lysis , leading to excess production of uric acid .</li><li>\u2022 Option A.</li><li>\u2022 Hyperuricemia</li><li>\u2022 TLS</li><li>\u2022 increased</li><li>\u2022 nucleic acids from rapid cell lysis</li><li>\u2022 uric acid</li><li>\u2022 Option B. Hyperkalemia results from the release of potassium , the most abundant intracellular cation , into the bloodstream when cells lyse .</li><li>\u2022 Option B.</li><li>\u2022 Hyperkalemia</li><li>\u2022 release of potassium</li><li>\u2022 intracellular cation</li><li>\u2022 bloodstream</li><li>\u2022 cells lyse</li><li>\u2022 Option C. Hyperphosphatemia occurs due to the release of intracellular phosphate into the extracellular fluid during cell lysis.</li><li>\u2022 Option C.</li><li>\u2022 Hyperphosphatemia</li><li>\u2022 intracellular phosphate into the extracellular fluid</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Tumor lysis syndrome is characterized by hyperuricemia, hyperkalemia, and hyperphosphatemia, but not hypercalcemia ; instead, hypocalcemia occurs due to the complexing of calcium with elevated phosphate levels .</li><li>\u27a4 Tumor lysis</li><li>\u27a4 hyperuricemia, hyperkalemia, and hyperphosphatemia,</li><li>\u27a4 not hypercalcemia</li><li>\u27a4 hypocalcemia</li><li>\u27a4 complexing of calcium with elevated phosphate levels</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "120daa0a",
      "audio": ""
    },
    {
      "text": "In reviewing the pathology report for a patient diagnosed with colonic adenocarcinoma, which of the following findings is most indicative of the tumor's grade?",
      "options": [
        {
          "label": "A",
          "text": "Number of positive lymph nodes",
          "correct": false
        },
        {
          "label": "B",
          "text": "Size of the tumor",
          "correct": false
        },
        {
          "label": "C",
          "text": "Metastatic spread to another organ",
          "correct": false
        },
        {
          "label": "D",
          "text": "Number of mitotic figures per high power-field",
          "correct": true
        }
      ],
      "correct_answer": "D. Number of mitotic figures per high power-field",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Number of mitotic figures per high power field.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. While the number of positive lymph nodes is crucial for staging a tumor under the 'N' category in the TNM classification system , it does not determine the histologic grade of the tumor .</li><li>\u2022 Option A.</li><li>\u2022 the number of positive lymph nodes</li><li>\u2022 staging a tumor</li><li>\u2022 'N' category in the TNM classification system</li><li>\u2022 does not</li><li>\u2022 histologic grade of the tumor</li><li>\u2022 Option B. The size of the tumor is used to determine the 'T' category in the TNM system and contributes to the staging, but not grading, of cancer .</li><li>\u2022 Option B.</li><li>\u2022 size of the tumor</li><li>\u2022 'T' category in the TNM system</li><li>\u2022 staging,</li><li>\u2022 not grading, of cancer</li><li>\u2022 Option C. The presence of metastasis is classified under the 'M' category of the TNM system and, like A and B, is used in staging rather than grading.</li><li>\u2022 Option C.</li><li>\u2022 presence of metastasis</li><li>\u2022 'M' category of the TNM system</li><li>\u2022 A and B, is used in staging</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The grade of a tumor is determined by its histologic differentiation, which includes the assessment of mitotic activity , specifically the number of mitotic figures per high power field , and not by the TNM staging factors such as tumor size, nodal involvement, or metastasis .</li><li>\u27a4 grade of a tumor</li><li>\u27a4 histologic differentiation,</li><li>\u27a4 assessment of mitotic activity</li><li>\u27a4 number of mitotic figures</li><li>\u27a4 high power field</li><li>\u27a4 not</li><li>\u27a4 TNM staging factors</li><li>\u27a4 tumor size, nodal involvement, or metastasis</li><li>\u27a4 Ref : Robbins and Cotran pathologic basis of disease 10th edition page: 246</li><li>\u27a4 Ref</li><li>\u27a4 : Robbins and Cotran pathologic basis of disease 10th edition page: 246</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f20b9f31",
      "audio": ""
    },
    {
      "text": "A 60-year-old male presents to his family physician because of complaints of blood in his stool and intermittent constipation. Fecal occult blood testing is positive. A colonoscopy is performed, revealing a large adenocarcinoma of the sigmoid colon. As the tumor was removed, a researcher tested the tumor and identified a mutation of RAS gene. Of the following, what was one mechanism by which the tumor developed?",
      "options": [
        {
          "label": "A",
          "text": "Inhibition of apoptosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Abnormal GTPase activity",
          "correct": true
        },
        {
          "label": "C",
          "text": "Abnormal tyrosine kinase activity",
          "correct": false
        },
        {
          "label": "D",
          "text": "Up-regulation of cytokine receptor",
          "correct": false
        }
      ],
      "correct_answer": "B. Abnormal GTPase activity",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Abnormal GTPase activity</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: While inhibition of apoptosis is a common mechanism in tumorigenesis , mutations in the RAS gene typically do not result in the direct inhibition of apoptotic pathways .</li><li>\u2022 Option A:</li><li>\u2022 inhibition of apoptosis</li><li>\u2022 tumorigenesis</li><li>\u2022 mutations</li><li>\u2022 RAS gene</li><li>\u2022 do not</li><li>\u2022 direct inhibition of apoptotic pathways</li><li>\u2022 Option C: Abnormal tyrosine kinase activity is often associated with mutations in other proto-oncogenes and is not the primary mechanism of action for RAS mutations.</li><li>\u2022 Option C:</li><li>\u2022 Abnormal tyrosine kinase activity</li><li>\u2022 mutations</li><li>\u2022 proto-oncogenes</li><li>\u2022 not</li><li>\u2022 RAS mutations.</li><li>\u2022 Option D: Up-regulation of cytokine receptor expression is a mechanism that could l ead to increased cell signaling for proliferation but is not directly related to RAS mutations.</li><li>\u2022 Option D:</li><li>\u2022 Up-regulation</li><li>\u2022 cytokine receptor</li><li>\u2022 ead to increased cell signaling for proliferation</li><li>\u2022 not</li><li>\u2022 RAS mutations.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Mutations in the RAS gene lead to abnormal GTPase activity, resulting in uncontrolled cell division and mitogenesis , which can contribute to tumorigenesis, such as in colon adenocarcinoma.</li><li>\u27a4 Mutations</li><li>\u27a4 RAS gene</li><li>\u27a4 abnormal GTPase activity,</li><li>\u27a4 uncontrolled cell division and mitogenesis</li><li>\u27a4 tumorigenesis,</li><li>\u27a4 colon adenocarcinoma.</li><li>\u27a4 Ref : Robbins and Cotran pathologic basis of disease 10th edition page: 286</li><li>\u27a4 Ref</li><li>\u27a4 : Robbins and Cotran pathologic basis of disease 10th edition page: 286</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "88ed35ff",
      "audio": ""
    },
    {
      "text": "A 40-year-old male with a past medical history significant for HIV infection has a CD4 count 120 cells/mm\u00b3 . The patient is started on antiretroviral therapy, and further evaluation is planned. All of the following are AIDS defining malignancies except?",
      "options": [
        {
          "label": "A",
          "text": "Non-Hodgkin\u2019s lymphoma",
          "correct": false
        },
        {
          "label": "B",
          "text": "Invasive cervical carcinoma",
          "correct": false
        },
        {
          "label": "C",
          "text": "Kaposi sarcoma",
          "correct": false
        },
        {
          "label": "D",
          "text": "Melanoma",
          "correct": true
        }
      ],
      "correct_answer": "D. Melanoma",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Melanoma</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: Non-Hodgkin\u2019s lymphoma , including primary lymphoma of the brain , is an AIDS-defining malignancy . This can be due to the weakened immune system's inability to control oncogenic viruses like EBV, which is associated with lymphoma.</li><li>\u2022 Option A:</li><li>\u2022 Non-Hodgkin\u2019s lymphoma</li><li>\u2022 primary lymphoma of the brain</li><li>\u2022 AIDS-defining malignancy</li><li>\u2022 due to the weakened immune system's</li><li>\u2022 oncogenic viruses</li><li>\u2022 EBV,</li><li>\u2022 lymphoma.</li><li>\u2022 Option B: Invasive cervical carcinoma is considered an AIDS-defining condition due to the association with human papillomavirus (HPV) and the increased risk of this malignancy in individuals with compromised immune systems .</li><li>\u2022 Option B:</li><li>\u2022 Invasive cervical carcinoma</li><li>\u2022 AIDS-defining</li><li>\u2022 human papillomavirus (HPV)</li><li>\u2022 increased risk of this malignancy</li><li>\u2022 compromised immune systems</li><li>\u2022 Option C: Kaposi sarcoma , caused by human herpesvirus 8 (HHV-8), is commonly seen in patients with AIDS and is one of the most recognizable AIDS-defining malignancies .</li><li>\u2022 Option C:</li><li>\u2022 Kaposi sarcoma</li><li>\u2022 human herpesvirus 8 (HHV-8),</li><li>\u2022 AIDS</li><li>\u2022 AIDS-defining malignancies</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Non-Hodgkin\u2019s lymphoma , invasive cervical carcinoma, and Kaposi sarcoma are considered AIDS-defining malignancies , which occur with increased frequency in patients with advanced HIV/AIDS due to their immunocompromised state . Melanoma is not part of this category.</li><li>\u27a4 Non-Hodgkin\u2019s lymphoma</li><li>\u27a4 invasive cervical carcinoma, and Kaposi sarcoma</li><li>\u27a4 AIDS-defining malignancies</li><li>\u27a4 increased frequency in patients</li><li>\u27a4 HIV/AIDS due to their immunocompromised state</li><li>\u27a4 Melanoma is not part of this category.</li><li>\u27a4 Ref : Robbins 10 th 256</li><li>\u27a4 Ref</li><li>\u27a4 : Robbins 10 th 256</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "505b9df3",
      "audio": ""
    },
    {
      "text": "A researcher is studying the metabolic activity of cancer cells and notes that despite adequate oxygen availability, the cells exhibit an increased rate of glycolysis followed by lactic acid fermentation. What is the primary reason for cancer cells to exhibit this metabolic pathway, known as the Warburg effect?",
      "options": [
        {
          "label": "A",
          "text": "To reduce the uptake of glucose",
          "correct": false
        },
        {
          "label": "B",
          "text": "To increase its lifespan and become immortal",
          "correct": false
        },
        {
          "label": "C",
          "text": "To enhance ATP production",
          "correct": false
        },
        {
          "label": "D",
          "text": "To make intermediated required for proliferation",
          "correct": true
        }
      ],
      "correct_answer": "D. To make intermediated required for proliferation",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) To make intermediated required for proliferation</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. The Warburg effect is characterized by an increased uptake of glucose , not a reduction , as cancer cells have high energy demands .</li><li>\u2022 Option A.</li><li>\u2022 Warburg effect</li><li>\u2022 increased uptake of glucose</li><li>\u2022 not a reduction</li><li>\u2022 cancer cells have high energy demands</li><li>\u2022 Option B. While the Warburg effect contributes to the cancer cells' survival , it does not directly increase their lifespan or cause immortality . Instead, it supports the high metabolic demands of proliferation.</li><li>\u2022 Option B.</li><li>\u2022 Warburg effect</li><li>\u2022 cancer cells' survival</li><li>\u2022 does not</li><li>\u2022 increase their lifespan</li><li>\u2022 immortality</li><li>\u2022 high metabolic demands of proliferation.</li><li>\u2022 Option C. The Warburg effect does not enhance ATP production since aerobic glycolysis is less efficient than oxidative phosphorylation , generating only 2 ATP molecules per glucose molecule compared to 36 ATP from oxidative phosphorylation.</li><li>\u2022 Option C.</li><li>\u2022 Warburg effect does not</li><li>\u2022 ATP production</li><li>\u2022 aerobic glycolysis is less efficient than oxidative phosphorylation</li><li>\u2022 2 ATP</li><li>\u2022 glucose molecule compared to 36 ATP</li><li>\u2022 oxidative phosphorylation.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Warburg effect , or aerobic glycolysis , in cancer cells is an adaptation that allows for the rapid synthesis of the macromolecules and organelles needed for cell growth and division , not for increased ATP production .</li><li>\u27a4 Warburg effect</li><li>\u27a4 aerobic glycolysis</li><li>\u27a4 rapid synthesis of the macromolecules</li><li>\u27a4 organelles</li><li>\u27a4 cell growth and division</li><li>\u27a4 not for increased ATP production</li><li>\u27a4 Ref : Robbins 10 th / 299</li><li>\u27a4 Ref</li><li>\u27a4 : Robbins 10 th / 299</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c57a8919",
      "audio": ""
    },
    {
      "text": "A woman presents to the gynecology clinic with genital lesions, as shown in the image. Upon examination, these lesions tests positive for a high-risk HPV subtype. Which of the following HPV subtypes is most likely the causative agent of her condition?",
      "options": [
        {
          "label": "A",
          "text": "6",
          "correct": false
        },
        {
          "label": "B",
          "text": "11",
          "correct": false
        },
        {
          "label": "C",
          "text": "18",
          "correct": true
        },
        {
          "label": "D",
          "text": "32",
          "correct": false
        }
      ],
      "correct_answer": "C. 18",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/02/untitled-550.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) 18</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. HPV-6 is associated with low-risk HPV infections, which typically cause genital warts , but are not highly associated with cervical cancer.</li><li>\u2022 Option A.</li><li>\u2022 HPV-6</li><li>\u2022 low-risk HPV infections,</li><li>\u2022 genital warts</li><li>\u2022 not highly associated with cervical cancer.</li><li>\u2022 Option B. Similar to HPV-6 , HPV-11 is also considered low-risk for cervical cancer and is more commonly associated with the development of genital warts .</li><li>\u2022 Option B.</li><li>\u2022 Similar to HPV-6</li><li>\u2022 HPV-11</li><li>\u2022 low-risk for cervical cancer</li><li>\u2022 genital warts</li><li>\u2022 Option D. HPV-32 is less commonly associated with cervical pathology and is not typically classified among the high-risk HPV subtypes responsible for cervical cancer .</li><li>\u2022 Option D.</li><li>\u2022 HPV-32</li><li>\u2022 less commonly</li><li>\u2022 cervical pathology</li><li>\u2022 not</li><li>\u2022 cervical cancer</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 High-risk HPV subtypes , particularly HPV-16 and HPV-18 , are most commonly associated with cervical cancer and its precursor lesions . While the scenario indicates a high-risk HPV subtype, the lesions depicted are characteristic of condylomata acuminata, typically caused by low-risk HPV subtypes.</li><li>\u27a4 High-risk HPV subtypes</li><li>\u27a4 HPV-16 and HPV-18</li><li>\u27a4 cervical cancer</li><li>\u27a4 its precursor lesions</li><li>\u27a4 indicates a high-risk HPV subtype,</li><li>\u27a4 condylomata acuminata,</li><li>\u27a4 low-risk HPV subtypes.</li><li>\u27a4 Ref : Robbins 10 th /1001</li><li>\u27a4 Ref</li><li>\u27a4 : Robbins 10 th /1001</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3674da7a",
      "audio": ""
    },
    {
      "text": "A middle-aged male presents with a painless, slow-growing swelling in the neck. Fine needle aspiration cytology (FNAC) is performed. For which of the following thyroid cancers is FNAC least likely to provide a definitive diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Papillary thyroid cancer",
          "correct": false
        },
        {
          "label": "B",
          "text": "Follicular thyroid cancer",
          "correct": true
        },
        {
          "label": "C",
          "text": "Medullary thyroid cancer",
          "correct": false
        },
        {
          "label": "D",
          "text": "Anapalstic thyroid cancer",
          "correct": false
        }
      ],
      "correct_answer": "B. Follicular thyroid cancer",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Follicular thyroid cancer</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. FNAC is highly effective for diagnosing papillary thyroid cancer due to characteristic cytological features such as nuclear grooves and pseudoinclusions.</li><li>\u2022 Option A.</li><li>\u2022 FNAC is highly effective</li><li>\u2022 papillary thyroid cancer</li><li>\u2022 nuclear grooves and pseudoinclusions.</li><li>\u2022 Option C. FNAC can suggest a diagnosis of medullary thyroid cancer by demonstrating amyloid and calcitonin-rich cells ; however, serum calcitonin levels and genetic testing are also important for diagnosis.</li><li>\u2022 Option C.</li><li>\u2022 FNAC can suggest</li><li>\u2022 medullary thyroid</li><li>\u2022 amyloid and calcitonin-rich cells</li><li>\u2022 serum calcitonin levels and genetic testing</li><li>\u2022 important for diagnosis.</li><li>\u2022 Option D. FNAC can often suggest anaplastic thyroid cancer due to the presence of highly atypical cells and necrotic material ; however, the aggressive nature of the disease often requires rapid additional diagnostic and therapeutic interventions.</li><li>\u2022 Option D.</li><li>\u2022 FNAC</li><li>\u2022 anaplastic thyroid cancer</li><li>\u2022 highly atypical cells and necrotic material</li><li>\u2022 aggressive nature of the disease</li><li>\u2022 diagnostic and therapeutic interventions.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 FNAC has limitations in diagnosing follicular thyroid cancer because it requires histological evidence of capsular or vascular invasion to differentiate between benign and malignant lesions , which cannot be determined by cytology alone .</li><li>\u27a4 FNAC</li><li>\u27a4 diagnosing follicular thyroid cancer</li><li>\u27a4 histological evidence of capsular</li><li>\u27a4 vascular invasion</li><li>\u27a4 benign and malignant lesions</li><li>\u27a4 cannot be determined by cytology alone</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "bf3a1457",
      "audio": ""
    },
    {
      "text": "An elderly female is being evaluated by her family physician for significant weight loss. Over the past 10 weeks, she has developed a velvety hyperpigmentation of the skin on the posterior neck and bilateral axilla. Her routine blood work is normal except for a hemoglobin level of 8.6 g/dL. Her HbA1c is 5.4%, and a plain chest radiograph is normal. What is the next step in the evaluation?",
      "options": [
        {
          "label": "A",
          "text": "Bone scan",
          "correct": false
        },
        {
          "label": "B",
          "text": "CT chest with contrast",
          "correct": false
        },
        {
          "label": "C",
          "text": "Skin Biopsy",
          "correct": false
        },
        {
          "label": "D",
          "text": "Upper and lower endoscopy",
          "correct": true
        }
      ],
      "correct_answer": "D. Upper and lower endoscopy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Upper and lower endoscopy</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. A bone scan might be useful in evaluating bone metastasis if there's suspicion for a metastatic process , but it's not the first step in the evaluation of a patient with suspected gastrointestinal malignancy and acanthosis nigricans.</li><li>\u2022 Option A.</li><li>\u2022 A bone scan</li><li>\u2022 bone metastasis</li><li>\u2022 metastatic process</li><li>\u2022 not the first step</li><li>\u2022 suspected gastrointestinal malignancy and acanthosis nigricans.</li><li>\u2022 Option B. While a CT chest with contrast could identify thoracic pathology , it wouldn't be the initial investigation for suspected gastric malignancy , especially with normal chest X-ray findings and the presence of acanthosis nigricans .</li><li>\u2022 Option B.</li><li>\u2022 CT chest with contrast</li><li>\u2022 thoracic pathology</li><li>\u2022 wouldn't be</li><li>\u2022 gastric malignancy</li><li>\u2022 normal chest X-ray findings and the presence of acanthosis nigricans</li><li>\u2022 Option C. A skin biopsy could confirm acanthosis nigricans but wouldn't address the underlying cause of the patient's systemic symptoms and weight loss.</li><li>\u2022 Option C.</li><li>\u2022 skin biopsy</li><li>\u2022 acanthosis nigricans</li><li>\u2022 wouldn't</li><li>\u2022 patient's systemic symptoms and weight loss.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In an elderly patient without obesity or diabetes, the presence of acanthosis nigricans and significant weight loss is concerning for an underlying malignancy, particularly gastrointestinal in origin , thus warranting endoscopic evaluation.</li><li>\u27a4 elderly patient</li><li>\u27a4 obesity or diabetes,</li><li>\u27a4 acanthosis nigricans</li><li>\u27a4 weight loss</li><li>\u27a4 underlying malignancy, particularly gastrointestinal in origin</li><li>\u27a4 endoscopic evaluation.</li><li>\u27a4 Ref : Robbins and Cotran pathologic basis of disease 10th edition page:329</li><li>\u27a4 Ref</li><li>\u27a4 : Robbins and Cotran pathologic basis of disease 10th edition page:329</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "26899747",
      "audio": ""
    },
    {
      "text": "A child presents to the OPD with proptosis. The mass responsible for same was biopsied and found to be a desmin positive tumor. Which of the following is the likely diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Leukemia",
          "correct": false
        },
        {
          "label": "B",
          "text": "Lymphoma",
          "correct": false
        },
        {
          "label": "C",
          "text": "Ewing sarcoma",
          "correct": false
        },
        {
          "label": "D",
          "text": "Embryonal rhabdomyosarcoma",
          "correct": true
        }
      ],
      "correct_answer": "D. Embryonal rhabdomyosarcoma",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/08/screenshot-2024-02-08-151003_DGH9row.jpg"
      ],
      "explanation": "<p><strong>Ans. D) Embryonal rhabdomyosarcoma</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Ref : Robbins 10 th /332</li><li>\u2022 Ref : Robbins 10 th /332</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "88a33cab",
      "audio": ""
    },
    {
      "text": "A 46-year-old female presents to her family physician because she palpated a nodule in her left breast during a breast self-examination. She subsequently undergoes a partial mastectomy. The mass is examined by a pathologist who makes a diagnosis of invasive ductal carcinoma. Subsequent genetic testing reveals a mutation of the BRCA2 gene. Of the following, what is the location for this mutation?",
      "options": [
        {
          "label": "A",
          "text": "17p",
          "correct": false
        },
        {
          "label": "B",
          "text": "17q",
          "correct": false
        },
        {
          "label": "C",
          "text": "13q",
          "correct": true
        },
        {
          "label": "D",
          "text": "13p",
          "correct": false
        }
      ],
      "correct_answer": "C. 13q",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) 13q</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. 17p refers to the short arm of chromosome 17 , which is where the gene for the p53 protein is located, not BRCA2 . p53 is commonly mutated in many forms of cancer.</li><li>\u2022 Option A.</li><li>\u2022 17p</li><li>\u2022 short arm of chromosome 17</li><li>\u2022 p53 protein</li><li>\u2022 not BRCA2</li><li>\u2022 Option B. 17q refers to the long arm of chromosome 17. This is the location of the BRCA1 gene , not BRCA2.</li><li>\u2022 Option B.</li><li>\u2022 17q</li><li>\u2022 long arm of chromosome 17.</li><li>\u2022 location of the BRCA1 gene</li><li>\u2022 Option D. 13p would refer to the short arm of chromosome 13 , which is not the correct location for the BRCA2 gene.</li><li>\u2022 Option D.</li><li>\u2022 13p</li><li>\u2022 short arm of chromosome 13</li><li>\u2022 not</li><li>\u2022 BRCA2 gene.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The BRCA2 gene is located on the long arm of chromosome 13 , at the cytogenetic band 13q .</li><li>\u27a4 BRCA2 gene</li><li>\u27a4 long arm of chromosome 13</li><li>\u27a4 cytogenetic band 13q</li><li>\u27a4 Ref : Robbins 10 th ed/ 293-4</li><li>\u27a4 Ref</li><li>\u27a4 : Robbins 10 th ed/ 293-4</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "23a7aa9f",
      "audio": ""
    },
    {
      "text": "A 28-year-old female presents with persistent cervical dysplasia on Pap smear. Further investigation reveals infection with high-risk HPV. Molecular analysis indicates the presence of a viral protein that interferes with the tumor suppressor Rb gene, promoting cell cycle progression. Which of the following protein produced by HPV suppresses Rb gene?",
      "options": [
        {
          "label": "A",
          "text": "E6",
          "correct": false
        },
        {
          "label": "B",
          "text": "E7",
          "correct": true
        },
        {
          "label": "C",
          "text": "LMP1",
          "correct": false
        },
        {
          "label": "D",
          "text": "Tax",
          "correct": false
        }
      ],
      "correct_answer": "B. E7",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) E7</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. The E6 protein of HPV is involved in the degradation of the p53 tumor suppressor protein , not the Rb protein . p53 is another critical regulator of the cell cycle and apoptosis.</li><li>\u2022 Option A.</li><li>\u2022 E6 protein of HPV</li><li>\u2022 p53 tumor suppressor protein</li><li>\u2022 not the Rb protein</li><li>\u2022 p53</li><li>\u2022 critical regulator of the cell cycle and apoptosis.</li><li>\u2022 Option C. LMP1 is an oncogenic protein associated with Epstein-Barr virus (EBV), not HPV. It is involved in the development of various lymphomas and nasopharyngeal carcinoma.</li><li>\u2022 Option C.</li><li>\u2022 LMP1</li><li>\u2022 oncogenic protein</li><li>\u2022 Epstein-Barr virus (EBV), not HPV.</li><li>\u2022 lymphomas and nasopharyngeal carcinoma.</li><li>\u2022 Option D. Tax is a protein associated with Human T-cell lymphotropic virus type 1 (HTLV-1), not HPV. It plays a role in the development of adult T-cell leukemia/lymphoma (ATLL).</li><li>\u2022 Option D.</li><li>\u2022 Tax</li><li>\u2022 Human T-cell lymphotropic virus type 1 (HTLV-1), not HPV.</li><li>\u2022 adult T-cell leukemia/lymphoma (ATLL).</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 E6 promotes the degradation of p53, and E7 inactivates the Rb protein , disrupting normal cell cycle control and contributing to the risk of cervical cancer development.</li><li>\u27a4 E6</li><li>\u27a4 degradation of p53, and E7 inactivates the Rb protein</li><li>\u27a4 normal cell cycle control</li><li>\u27a4 cervical cancer development.</li><li>\u27a4 Ref : Robbins 10 th /324</li><li>\u27a4 Ref</li><li>\u27a4 : Robbins 10 th /324</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ed296327",
      "audio": ""
    },
    {
      "text": "A 4-year-old boy is evaluated by his pediatrician for 1 week of intermittent hematuria. On examination he appears well developed and well nourished, except a right flank mass is palpable. A biopsy of the mass is performed, which reveals primitive looking small blue cells with glomerular and tubular structures (image). Which of the following indicates poor prognosis for the patient?",
      "options": [
        {
          "label": "A",
          "text": "Reduced rate of proliferation",
          "correct": false
        },
        {
          "label": "B",
          "text": "Absence of metastasis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Anaplasia",
          "correct": true
        },
        {
          "label": "D",
          "text": "Sparing of basement membrane",
          "correct": false
        }
      ],
      "correct_answer": "C. Anaplasia",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/08/screenshot-2024-02-08-194503.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Anaplasia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: Reduced rate of proliferation actually suggests a better prognosis as it indicates slower tumor growth.</li><li>\u2022 Option A:</li><li>\u2022 Reduced rate of proliferation</li><li>\u2022 Option B: Absence of metastasis is a favorable prognostic factor, not a poor prognostic indicator.</li><li>\u2022 Option B:</li><li>\u2022 Absence of metastasis</li><li>\u2022 Option D: Sparing of basement membrane suggests the tumor is less invasive, which is associated with better outcomes.</li><li>\u2022 Option D:</li><li>\u2022 Sparing of basement membrane</li><li>\u2022 Ref: Robbins and Cotran pathologic basis of disease 10th edition page: 292</li><li>\u2022 Ref: Robbins and Cotran pathologic basis of disease 10th edition page: 292</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "bb9e0866",
      "audio": ""
    },
    {
      "text": "In the context of tumor biology, which of the following statements is correct?",
      "options": [
        {
          "label": "A",
          "text": "BRCA1 is an oncogene",
          "correct": false
        },
        {
          "label": "B",
          "text": "EGFR positive in non small cell cancer",
          "correct": true
        },
        {
          "label": "C",
          "text": "Her 2 amplification is seen in most breast cancer",
          "correct": false
        },
        {
          "label": "D",
          "text": "N myc is a tumor suppressor gene",
          "correct": false
        }
      ],
      "correct_answer": "B. EGFR positive in non small cell cancer",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) EGFR positive in non small cell cancer</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. BRCA1 is not an oncogene but a tumor suppressor gene. Mutations in BRCA1 are associated with an increased risk of breast and ovarian cancers.</li><li>\u2022 Option A.</li><li>\u2022 BRCA1</li><li>\u2022 not an oncogene</li><li>\u2022 tumor suppressor gene. Mutations in BRCA1</li><li>\u2022 increased risk of</li><li>\u2022 breast and ovarian cancers.</li><li>\u2022 Option C. Her2 amplification occurs in some breast cancer cases but is not seen in the majority. It is significant because Her2 status can affect treatment options and prognosis.</li><li>\u2022 Option C.</li><li>\u2022 Her2</li><li>\u2022 some breast cancer</li><li>\u2022 not seen</li><li>\u2022 majority.</li><li>\u2022 Her2 status can affect treatment options and prognosis.</li><li>\u2022 Option D. N myc is a proto-oncogene , not a tumor suppressor gene . It can become an oncogene when mutated or overexpressed, as seen in some cases of neuroblastoma.</li><li>\u2022 Option D.</li><li>\u2022 N myc</li><li>\u2022 proto-oncogene</li><li>\u2022 not a tumor suppressor gene</li><li>\u2022 oncogene</li><li>\u2022 mutated or overexpressed,</li><li>\u2022 neuroblastoma.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 BRCA1 is a tumor suppressor gene , EGFR can be overexpressed in non-small cell lung cancer, Her2 is amplified in a subset of breast cancers , and N myc is a proto-oncogene associated with certain types of cancer (neuroblastoma).</li><li>\u27a4 BRCA1</li><li>\u27a4 suppressor gene</li><li>\u27a4 EGFR</li><li>\u27a4 non-small cell lung cancer,</li><li>\u27a4 Her2</li><li>\u27a4 subset of breast cancers</li><li>\u27a4 N myc</li><li>\u27a4 proto-oncogene</li><li>\u27a4 (neuroblastoma).</li><li>\u27a4 Ref : Robbins 10 th /285, 292</li><li>\u27a4 Ref</li><li>\u27a4 : Robbins 10 th /285, 292</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3b72ff27",
      "audio": ""
    },
    {
      "text": "A patient presents with a growth suspected to be related to a low risk HPV subtypes. Which of the following is most likely responsible with HPV strains 6 and 11?",
      "options": [
        {
          "label": "A",
          "text": "Cervical carcinoma",
          "correct": false
        },
        {
          "label": "B",
          "text": "Oral carcinoma",
          "correct": false
        },
        {
          "label": "C",
          "text": "Laryngeal papillomatosis",
          "correct": true
        },
        {
          "label": "D",
          "text": "Anorectal carcinoma",
          "correct": false
        }
      ],
      "correct_answer": "C. Laryngeal papillomatosis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Laryngeal papillomatosis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Cervical carcinoma is typically caused by high-risk HPV strains such as HPV-16 and HPV-18 , not the low-risk strains that cause laryngeal papillomatosis .</li><li>\u2022 Option A.</li><li>\u2022 Cervical carcinoma</li><li>\u2022 high-risk HPV strains</li><li>\u2022 HPV-16 and HPV-18</li><li>\u2022 not the low-risk strains</li><li>\u2022 laryngeal papillomatosis</li><li>\u2022 Option B. Oral carcinoma can also be caused by high-risk HPV strains , particularly HPV-16 , which is associated with oropharyngeal cancers .</li><li>\u2022 Option B.</li><li>\u2022 Oral carcinoma</li><li>\u2022 high-risk HPV strains</li><li>\u2022 HPV-16</li><li>\u2022 oropharyngeal cancers</li><li>\u2022 Option D. Anorectal carcinoma is associated with high-risk HPV strains , similar to cervical and oral carcinomas .</li><li>\u2022 Option D.</li><li>\u2022 Anorectal carcinoma</li><li>\u2022 high-risk HPV strains</li><li>\u2022 cervical and oral carcinomas</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Low-risk HPV strains , such as HPV-6 and HPV-11, are associated with benign conditions such as laryngeal papillomatosis, while high-risk HPV strains are associated with malignancies like cervical, oral, and anorectal carcinoma.</li><li>\u27a4 Low-risk HPV strains</li><li>\u27a4 HPV-6 and HPV-11,</li><li>\u27a4 benign conditions such as laryngeal papillomatosis,</li><li>\u27a4 high-risk HPV strains</li><li>\u27a4 cervical, oral, and anorectal carcinoma.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "29cf647b",
      "audio": ""
    },
    {
      "text": "45-year-old woman is diagnosed with breast cancer, and her tumor cells demonstrate overexpression of the HER2/neu proto-oncogene. What is the primary mechanism by which HER2/neu contributes to the pathophysiology of her cancer?",
      "options": [
        {
          "label": "A",
          "text": "Inhibition of cell proliferation",
          "correct": false
        },
        {
          "label": "B",
          "text": "Promotion of apoptosis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Stimulation of angiogenesis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Activation of cell signaling pathways",
          "correct": true
        }
      ],
      "correct_answer": "D. Activation of cell signaling pathways",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Activation of cell signaling pathways</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Inhibition of cell proliferation is not associated with HER2/neu overexpression; instead, HER2/neu leads to increased cell proliferation .</li><li>\u2022 Option A.</li><li>\u2022 Inhibition of cell proliferation</li><li>\u2022 not</li><li>\u2022 HER2/neu overexpression;</li><li>\u2022 HER2/neu</li><li>\u2022 increased cell proliferation</li><li>\u2022 Option B. Promotion of apoptosis is not a mechanism of HER2/neu action . In contrast, HER2/neu overexpression tends to confer resistance to apoptotic signals .</li><li>\u2022 Option B.</li><li>\u2022 Promotion of apoptosis</li><li>\u2022 not</li><li>\u2022 HER2/neu action</li><li>\u2022 HER2/neu overexpression</li><li>\u2022 resistance to apoptotic signals</li><li>\u2022 Option C. While HER2/neu overexpression can have d ownstream effects that might indirectly promote angiogenesis , this is not the primary action of the proto-oncogene.</li><li>\u2022 Option C.</li><li>\u2022 HER2/neu</li><li>\u2022 ownstream effects</li><li>\u2022 indirectly promote angiogenesis</li><li>\u2022 not the primary action of the proto-oncogene.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Overexpression of the HER2/neu proto-oncogene in breast cancer leads to the activation of cell signaling pathways that promote cell proliferation and survival. This overexpression is associated with a more aggressive disease phenotype and a poorer prognosis . Targeted therapies against HER2/neu can be effective in treating tumors with this over-expression .</li><li>\u27a4 Overexpression of the HER2/neu proto-oncogene in breast cancer</li><li>\u27a4 cell signaling pathways</li><li>\u27a4 cell proliferation and survival.</li><li>\u27a4 more aggressive disease phenotype and a poorer prognosis</li><li>\u27a4 Targeted</li><li>\u27a4 against HER2/neu</li><li>\u27a4 treating tumors with this over-expression</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b3637104",
      "audio": ""
    },
    {
      "text": "A 35-year-old male presents to his family care physician because of balance problems. A CT scan of his head reveals a mass near the pontomedullary junction. The mass is excised and diagnosed as a schwannoma. Four years later, he presents with headaches and is found to have two meningiomas. Of the following, what is the most likely mutation that he possesses?",
      "options": [
        {
          "label": "A",
          "text": "Mutation of the PTEN",
          "correct": false
        },
        {
          "label": "B",
          "text": "Mutation of the CDKN2 gene",
          "correct": false
        },
        {
          "label": "C",
          "text": "Mutation of the NF2 gene",
          "correct": true
        },
        {
          "label": "D",
          "text": "Mutation of the WT",
          "correct": false
        }
      ],
      "correct_answer": "C. Mutation of the NF2 gene",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Mutation of the NF2 gene</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Mutations of PTEN are associated with colonic adenocarcinoma , breast and thyroid tumors .</li><li>\u2022 Option A.</li><li>\u2022 Mutations of PTEN</li><li>\u2022 colonic adenocarcinoma</li><li>\u2022 breast and thyroid tumors</li><li>\u2022 Option B. Mutations of CDKN2 are associated with familial melanoma</li><li>\u2022 Option B.</li><li>\u2022 Mutations of CDKN2</li><li>\u2022 familial melanoma</li><li>\u2022 Option D. Mutations of WT are associated with Wilms tumor</li><li>\u2022 Option D.</li><li>\u2022 Mutations of WT</li><li>\u2022 Wilms tumor</li><li>\u2022 NF1, neurofibromin 1 , is a tumor suppressor gene found on chromosome 17q11.2 NF2, merlin or schannomin, is a tumor suppressor gene on chromosome  22q11-13.1</li><li>\u2022 NF1, neurofibromin 1 , is a tumor suppressor gene found on chromosome 17q11.2</li><li>\u2022 NF1, neurofibromin 1</li><li>\u2022 tumor suppressor gene</li><li>\u2022 chromosome 17q11.2</li><li>\u2022 NF2, merlin or schannomin, is a tumor suppressor gene on chromosome  22q11-13.1</li><li>\u2022 NF2, merlin or schannomin,</li><li>\u2022 tumor suppressor gene</li><li>\u2022 chromosome  22q11-13.1</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 The NF2 gene encodes a protein called merlin or schwannomin and is associated with Neurofibromatosis type II , which is characterized by multiple central nervous system tumors including schwannomas, meningiomas, and ependymomas.</li><li>\u2022 The NF2 gene</li><li>\u2022 protein</li><li>\u2022 merlin or schwannomin</li><li>\u2022 Neurofibromatosis type II</li><li>\u2022 multiple central nervous system tumors</li><li>\u2022 schwannomas, meningiomas, and ependymomas.</li><li>\u2022 Ref : Robbins and Cotran pathologic basis of disease 10th edition page:292 table: 7.7</li><li>\u2022 Ref</li><li>\u2022 : Robbins and Cotran pathologic basis of disease 10th edition page:292 table: 7.7</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "115d2305",
      "audio": ""
    },
    {
      "text": "A 32-year-old man presents to the emergency department with persistent abdominal pain and diarrhea. CT scan reveals the presence of a tumor in the pancreas. Biopsy confirms the diagnosis of pancreatic adenocarcinoma. Genetic testing reveals a mutation in the KRAS proto-oncogene. Which of the following best describes the role of KRAS in this case?",
      "options": [
        {
          "label": "A",
          "text": "Stimulation of apoptosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Inhibition of angiogenesis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Activation of cell cycle arrest",
          "correct": false
        },
        {
          "label": "D",
          "text": "Promotion of cell proliferation",
          "correct": true
        }
      ],
      "correct_answer": "D. Promotion of cell proliferation",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Promotion of cell proliferation</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 KRAS is a proto-oncogene that encodes for a protein involved in cell signaling pathways that regulate cell growth and division . Mutations in KRAS can lead to the activation of these pathways, promoting cell proliferation and survival . KRAS mutations are common in pancreatic adenocarcinoma and are associated with a poorer prognosis</li><li>\u2022 KRAS</li><li>\u2022 proto-oncogene</li><li>\u2022 cell signaling pathways</li><li>\u2022 cell growth and division</li><li>\u2022 Mutations in KRAS</li><li>\u2022 activation of these pathways, promoting cell proliferation and survival</li><li>\u2022 KRAS mutations</li><li>\u2022 pancreatic adenocarcinoma</li><li>\u2022 poorer prognosis</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "709690c8",
      "audio": ""
    },
    {
      "text": "A 30-year-old woman presents to her primary care physician for a routine health check-up. She has no complaints and her medical history is unremarkable. She undergoes a Pap smear as part of her cervical cancer screening. The cytology report describes disorganized growth of cells with hyperchromatic nuclei. Which of the following best characterizes the cellular changes seen in this patient's Pap smear?",
      "options": [
        {
          "label": "A",
          "text": "Hypertrophy",
          "correct": false
        },
        {
          "label": "B",
          "text": "Dysplasia",
          "correct": true
        },
        {
          "label": "C",
          "text": "Metaplasia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Hyperplasia",
          "correct": false
        }
      ],
      "correct_answer": "B. Dysplasia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Dysplasia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Hypertrophy: Hypertrophy refers to an increase in the size of cells , leading to an increase in the size of the organ . It is usually seen in response to increased demand or stimulation by hormones or growth factors . Unlike hyperplasia , hypertrophy does not involve an increase in the number of cells . An example would be the increase in muscle mass due to exercise.</li><li>\u2022 Option A. Hypertrophy:</li><li>\u2022 increase in the size of cells</li><li>\u2022 increase in the size of the organ</li><li>\u2022 increased demand or stimulation by hormones or growth factors</li><li>\u2022 Unlike hyperplasia</li><li>\u2022 does not involve</li><li>\u2022 increase in the number of cells</li><li>\u2022 increase in muscle mass due to exercise.</li><li>\u2022 Option C. Metaplasia: Metaplasia is the reversible change from one type of cell to another due to abnormal stimulus , which can potentially predispose to malignancy if the stimulus persists . A classic example is Barrett\u2019s esophagus , where the normal squamous epithelium of the esophagus changes to a columnar epithelium in response to chronic gastric acid exposure .</li><li>\u2022 Option C. Metaplasia:</li><li>\u2022 reversible change from one type of cell to another due to abnormal stimulus</li><li>\u2022 predispose to malignancy</li><li>\u2022 persists</li><li>\u2022 Barrett\u2019s esophagus</li><li>\u2022 normal squamous epithelium of the esophagus changes to a columnar epithelium</li><li>\u2022 chronic gastric acid exposure</li><li>\u2022 Option D. Hyperplasia: Hyperplasia is an increase in the number of cells in an organ or tissue, which may subsequently increase the size of the organ or tissue. It is a response to a stimulus and is usually a controlled process . Hyperplasia can be a physiological response , such as the proliferation of glandular epithelium of the female breast at puberty or pathologic as seen in endometrial hyperplasia.</li><li>\u2022 Option D. Hyperplasia:</li><li>\u2022 an increase in the number of cells in an organ or tissue,</li><li>\u2022 increase the size of the organ or tissue.</li><li>\u2022 stimulus</li><li>\u2022 controlled process</li><li>\u2022 Hyperplasia</li><li>\u2022 physiological response</li><li>\u2022 proliferation of glandular epithelium</li><li>\u2022 female breast at puberty or pathologic</li><li>\u2022 endometrial hyperplasia.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Dysplasia, is a term used to describe disorganized growth of cells with varying size, shape, and orientation, often with hyperchromatic nuclei, suggestive of a precancerous state .</li><li>\u27a4 Dysplasia,</li><li>\u27a4 disorganized growth of cells with varying size, shape, and orientation,</li><li>\u27a4 hyperchromatic nuclei,</li><li>\u27a4 precancerous state</li><li>\u27a4 Ref : Robbins 10th/e p719-720</li><li>\u27a4 Ref</li><li>\u27a4 : Robbins 10th/e p719-720</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "041743d6",
      "audio": ""
    },
    {
      "text": "A 56-year-old man was working in a benzene factory for a long time. He retired 5 years ago. What would be the possible complication in this patient?",
      "options": [
        {
          "label": "A",
          "text": "Bladder cancer",
          "correct": false
        },
        {
          "label": "B",
          "text": "Blood cancer",
          "correct": true
        },
        {
          "label": "C",
          "text": "Lung cancer",
          "correct": false
        },
        {
          "label": "D",
          "text": "Skin cancer",
          "correct": false
        }
      ],
      "correct_answer": "B. Blood cancer",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Blood cancer</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Bladder cancer: Bladder cancer is typically associated with exposure to aromatic amines and chemicals used in the dye industry . Although occupational exposure is a risk factor , benzene exposure is not traditionally linked with bladder cancer .</li><li>\u2022 Option A. Bladder cancer:</li><li>\u2022 exposure to aromatic amines</li><li>\u2022 chemicals</li><li>\u2022 dye industry</li><li>\u2022 occupational exposure</li><li>\u2022 risk factor</li><li>\u2022 benzene</li><li>\u2022 not</li><li>\u2022 bladder cancer</li><li>\u2022 Option C. Lung cancer: While lung cancer is often associated with occupational exposures, particularly to substances like asbestos or radon, benzene is not strongly linked to lung cancer . Smoking remains the primary risk factor for lung cancer .</li><li>\u2022 Option C. Lung cancer:</li><li>\u2022 with occupational exposures,</li><li>\u2022 asbestos or radon, benzene</li><li>\u2022 not strongly</li><li>\u2022 lung cancer</li><li>\u2022 Smoking</li><li>\u2022 primary risk factor for lung cancer</li><li>\u2022 Option D. Skin cancer: Exposure to ultraviolet (UV) radiation is the most significant risk factor for skin cancer. Some chemicals can increase the risk of skin cancer , but benzene is not typically implicated in this type of malignancy.</li><li>\u2022 Option D. Skin cancer:</li><li>\u2022 ultraviolet (UV) radiation</li><li>\u2022 risk factor for skin cancer.</li><li>\u2022 increase the risk of skin cancer</li><li>\u2022 benzene is not</li><li>\u2022 malignancy.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Benzene exposure , especially in occupational settings , is associated with an increased risk of hematological malignancies, particularly acute myeloid leukemia , due to its metabolism to toxic compounds that disrupt cell differentiation in the bone marrow.</li><li>\u27a4 Benzene exposure</li><li>\u27a4 occupational settings</li><li>\u27a4 increased risk of hematological malignancies,</li><li>\u27a4 acute myeloid leukemia</li><li>\u27a4 its metabolism to toxic compounds</li><li>\u27a4 cell differentiation in the bone marrow.</li><li>\u27a4 Ref : Robbins 10th/e p198</li><li>\u27a4 Ref</li><li>\u27a4 : Robbins 10th/e p198</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8f50cce5",
      "audio": ""
    },
    {
      "text": "An 8-year-old child is referred to a dermatologist for several \"suspicious\" pigmented lesions on his face and neck. Further history reveals the patient has had problems seeing out of his right eye; he is referred to an ophthalmologist, who diagnoses ocular melanoma. Based on the patient\u2019s symptoms, the diagnosis of xeroderma pigmentosum is considered. This condition results from?",
      "options": [
        {
          "label": "A",
          "text": "Aberrant expression of a receptor tyrosine kinase",
          "correct": false
        },
        {
          "label": "B",
          "text": "An inborn defect in DNA repair",
          "correct": true
        },
        {
          "label": "C",
          "text": "Chemical carcinogenesis",
          "correct": false
        },
        {
          "label": "D",
          "text": "DNA viral infection",
          "correct": false
        }
      ],
      "correct_answer": "B. An inborn defect in DNA repair",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) An inborn defect in DNA repair</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Aberrant expression of the gene for a receptor tyrosine kinase , such as the Her-2/neu gene product , can cause breast cancer .</li><li>\u2022 Option A.</li><li>\u2022 Aberrant expression</li><li>\u2022 gene</li><li>\u2022 receptor tyrosine kinase</li><li>\u2022 Her-2/neu gene product</li><li>\u2022 breast cancer</li><li>\u2022 Option C. Chemical carcinogens have highly reactive electrophile groups that directly damage DNA , leading to mutations and eventually cancer .</li><li>\u2022 Option C.</li><li>\u2022 Chemical carcinogens</li><li>\u2022 highly reactive electrophile groups</li><li>\u2022 damage DNA</li><li>\u2022 mutations and eventually cancer</li><li>\u2022 Option D. A retrovirus is responsible for the development of T-cell leukemia/lymphoma .</li><li>\u2022 Option D.</li><li>\u2022 retrovirus</li><li>\u2022 development of T-cell leukemia/lymphoma</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Xeroderma pigmentosum is a condition resulting from a hereditary deficiency in the nucleotide excision repair pathway , leading to an inability to repair UV-induced thymine dimers , with resultant increased skin and ocular malignancies .</li><li>\u27a4 Xeroderma pigmentosum</li><li>\u27a4 hereditary deficiency</li><li>\u27a4 nucleotide excision repair pathway</li><li>\u27a4 inability to repair UV-induced thymine dimers</li><li>\u27a4 increased skin and ocular malignancies</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "04bb66d4",
      "audio": ""
    },
    {
      "text": "A patient presents with a family history of colon cancer. They undergo genetic testing, which reveals a mutation in the APC gene. Which of the following is true about APC?",
      "options": [
        {
          "label": "A",
          "text": "It is a proto-oncogene",
          "correct": false
        },
        {
          "label": "B",
          "text": "It is involved in DNA repair",
          "correct": false
        },
        {
          "label": "C",
          "text": "It is a tumor suppressor gene",
          "correct": true
        },
        {
          "label": "D",
          "text": "It is not involved in colon cancer",
          "correct": false
        }
      ],
      "correct_answer": "C. It is a tumor suppressor gene",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) It is a tumor suppressor gene</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A.  It is a proto-oncogene. Proto-oncogenes are normal genes that can become oncogenes due to mutations or increased expression . Oncogenes can cause the cells to grow and proliferate excessively . The APC gene , however, functions as a tumor suppressor gene, not a proto-oncogene.</li><li>\u2022 Option A.  It is a proto-oncogene.</li><li>\u2022 normal genes</li><li>\u2022 oncogenes due to mutations or increased expression</li><li>\u2022 Oncogenes</li><li>\u2022 cells to grow and proliferate excessively</li><li>\u2022 APC gene</li><li>\u2022 tumor suppressor gene, not a proto-oncogene.</li><li>\u2022 Option B. It is involved in DNA repair. While DNA repair mechanisms are essential in the prevention of cancer , the APC gene itself is not primarily involved in DNA repair processes . Its primary function relates to the regulation of cell growth and division.</li><li>\u2022 Option B. It is involved in DNA repair.</li><li>\u2022 DNA repair</li><li>\u2022 prevention of cancer</li><li>\u2022 APC gene itself is not</li><li>\u2022 DNA repair processes</li><li>\u2022 primary function</li><li>\u2022 regulation of cell growth and division.</li><li>\u2022 Option D. It is not involved in colon cancer. This statement is incorrect . The APC gene is implicated in colon cancer , as mutations in this gene are commonly found in both sporadic and hereditary forms of colorectal cancer .</li><li>\u2022 Option D. It is not involved in colon cancer.</li><li>\u2022 incorrect</li><li>\u2022 APC gene</li><li>\u2022 colon cancer</li><li>\u2022 mutations</li><li>\u2022 gene</li><li>\u2022 both sporadic and hereditary forms of colorectal cancer</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 APC gene is a tumor suppressor gene. Mutations in the APC gene lead to a loss of function , resulting in increased cell proliferation and a higher risk for developing colorectal cancer .</li><li>\u27a4 APC gene</li><li>\u27a4 tumor suppressor gene.</li><li>\u27a4 APC gene</li><li>\u27a4 loss of function</li><li>\u27a4 increased cell proliferation and a higher risk for developing colorectal cancer</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8afdfd8e",
      "audio": ""
    },
    {
      "text": "A patient presents with a history of breast cancer. They undergo genetic testing, which reveals a mutation in the BRCA1 gene. Which of the following is true about BRCA1?",
      "options": [
        {
          "label": "A",
          "text": "It is a proto-oncogene",
          "correct": false
        },
        {
          "label": "B",
          "text": "It is involved in cell cycle regulation",
          "correct": false
        },
        {
          "label": "C",
          "text": "It is a tumor suppressor gene",
          "correct": true
        },
        {
          "label": "D",
          "text": "It is not involved in breast cancer",
          "correct": false
        }
      ],
      "correct_answer": "C. It is a tumor suppressor gene",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) It is a tumor suppressor gene</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. It is a proto-oncogene. Proto-oncogenes are genes that normally help cells grow . When a proto-oncogene mutates or becomes overactive , it becomes an oncogene and can lead to cancer . BRCA1 , however, is known as a tumor suppressor gene .</li><li>\u2022 Option A. It is a proto-oncogene.</li><li>\u2022 genes</li><li>\u2022 cells grow</li><li>\u2022 proto-oncogene mutates or becomes overactive</li><li>\u2022 oncogene</li><li>\u2022 lead to cancer</li><li>\u2022 BRCA1</li><li>\u2022 tumor suppressor gene</li><li>\u2022 Option B. It is involved in cell cycle regulation. While the BRCA1 gene does play a role in cell cycle regulation as part of its function in response to DNA damage , it is more specifically characterized as a gene involved in DNA repair pathways, particularly double-strand break repair .</li><li>\u2022 Option B. It is involved in cell cycle regulation.</li><li>\u2022 BRCA1 gene</li><li>\u2022 cell cycle regulation</li><li>\u2022 function</li><li>\u2022 DNA damage</li><li>\u2022 more</li><li>\u2022 gene</li><li>\u2022 DNA repair pathways,</li><li>\u2022 double-strand break repair</li><li>\u2022 Option D. It is not involved in breast cancer. This statement is incorrect as mutations in the BRCA1 gene are well-established risk factors for breast cancer , as well as ovarian cancer.</li><li>\u2022 Option D. It is not involved in breast cancer.</li><li>\u2022 incorrect</li><li>\u2022 BRCA1 gene are well-established risk factors</li><li>\u2022 breast cancer</li><li>\u2022 ovarian cancer.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 BRCA1 gene is a tumor suppressor gene involved in DNA repair . Mutations in BRCA1 increase the risk of breast and ovarian cancers by impairing the repair of DNA damage, which prevents the proper regulation of cell growth and division, thereby contributing to tumorigenesis.</li><li>\u27a4 BRCA1 gene</li><li>\u27a4 tumor suppressor gene</li><li>\u27a4 DNA repair</li><li>\u27a4 Mutations in BRCA1</li><li>\u27a4 risk of breast and ovarian cancers</li><li>\u27a4 prevents</li><li>\u27a4 proper regulation of cell growth and division,</li><li>\u27a4 tumorigenesis.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "aac2a1e2",
      "audio": ""
    },
    {
      "text": "A 42-year-old male undergoes a colectomy. The pathologist identifies more than 100 polyps in the resected specimen as well as a focus of invasive adenocarcinoma. Of the following, what is the functional mechanism of the gene mutation causing his disease process?",
      "options": [
        {
          "label": "A",
          "text": "Decreased breakdown of \u03b2-catenin",
          "correct": true
        },
        {
          "label": "B",
          "text": "Increased breakdown of \u03b2-catenin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Lack of production of \u03b2-catenin",
          "correct": false
        },
        {
          "label": "D",
          "text": "Decreased activity of \u03b2-catenin",
          "correct": false
        }
      ],
      "correct_answer": "A. Decreased breakdown of \u03b2-catenin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Decreased breakdown of \u03b2-catenin</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Increased breakdown of \u03b2-catenin: An increased breakdown of \u03b2-catenin would actually be a protective mechanism against the development of neoplasia , as it would prevent the excessive cell proliferation associated with colorectal cancer . This is not the mechanism involved in FAP .</li><li>\u2022 Option B. Increased breakdown of \u03b2-catenin:</li><li>\u2022 protective mechanism against the development of neoplasia</li><li>\u2022 prevent</li><li>\u2022 excessive cell proliferation</li><li>\u2022 colorectal cancer</li><li>\u2022 not the mechanism involved in FAP</li><li>\u2022 Option C. Lack of production of \u03b2-catenin: FAP is not characterized by a lack of production of \u03b2-catenin . Instead, \u03b2-catenin production is normal , but its breakdown is impaired due to the non-functional APC protein.</li><li>\u2022 Option C. Lack of production of \u03b2-catenin:</li><li>\u2022 FAP</li><li>\u2022 not</li><li>\u2022 lack of production of \u03b2-catenin</li><li>\u2022 \u03b2-catenin production is normal</li><li>\u2022 its breakdown</li><li>\u2022 impaired</li><li>\u2022 non-functional APC protein.</li><li>\u2022 Option D. Decreased activity of \u03b2-catenin In FAP , \u03b2-catenin activity is not decreased . In fact, due to the loss of APC function and decreased breakdown of \u03b2-catenin , its activity within the Wnt signaling pathway is increased , leading to enhanced transcription of proliferation genes .</li><li>\u2022 Option D. Decreased activity of \u03b2-catenin</li><li>\u2022 FAP</li><li>\u2022 \u03b2-catenin</li><li>\u2022 not decreased</li><li>\u2022 due to the loss of APC function and decreased breakdown of \u03b2-catenin</li><li>\u2022 Wnt signaling pathway is increased</li><li>\u2022 transcription of proliferation genes</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In Familial Adenomatous Polyposis , mutations in the APC tumor suppressor gene lead to decreased breakdown of \u03b2-catenin , which accumulates in the nucleus and activates transcription factors that promote cell proliferation and reduce apoptosis , contributing to the development of colorectal neoplasia . APC is also called as Gatekeeper of Colonic Neoplasia and its locus is on chromosome 5q21.</li><li>\u27a4 Familial Adenomatous Polyposis</li><li>\u27a4 mutations</li><li>\u27a4 APC tumor suppressor gene</li><li>\u27a4 decreased breakdown of \u03b2-catenin</li><li>\u27a4 accumulates in the nucleus and activates transcription factors</li><li>\u27a4 cell proliferation and reduce apoptosis</li><li>\u27a4 development of colorectal neoplasia</li><li>\u27a4 APC</li><li>\u27a4 Gatekeeper of Colonic Neoplasia</li><li>\u27a4 locus is on chromosome 5q21.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ef3d6b00",
      "audio": ""
    },
    {
      "text": "Identify the false statement?",
      "options": [
        {
          "label": "A",
          "text": "Telomerase is not active in somatic cells",
          "correct": false
        },
        {
          "label": "B",
          "text": "It is a reverse transcriptase",
          "correct": false
        },
        {
          "label": "C",
          "text": "It's activity is more in Germ cells than stem cells",
          "correct": false
        },
        {
          "label": "D",
          "text": "Double stranded breaks is repaired by telomerase",
          "correct": true
        }
      ],
      "correct_answer": "D. Double stranded breaks is repaired by telomerase",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Double stranded breaks is repaired by telomerase</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Telomerase activity is absent in most normal human somatic cells because of the lack of expression of TERT</li><li>\u2022 Option A.</li><li>\u2022 Telomerase activity</li><li>\u2022 absent</li><li>\u2022 normal human somatic cells</li><li>\u2022 lack of expression of TERT</li><li>\u2022 Option B. Telomerase core enzyme is composed of a reverse transcriptase subunit and a non-coding RNA used as a template for elongation .</li><li>\u2022 Option B.</li><li>\u2022 Telomerase core enzyme</li><li>\u2022 reverse transcriptase</li><li>\u2022 non-coding RNA</li><li>\u2022 template for elongation</li><li>\u2022 Option C. Germ cells and stem cells have high telomerase activity</li><li>\u2022 Option C.</li><li>\u2022 Germ cells and stem cells</li><li>\u2022 high telomerase activity</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Telomerase is not responsible for repairing double-stranded DNA breaks . Its main function is to elongate telomeres , which are the protective ends of chromosomes , using an RNA template that is part of the enzyme .</li><li>\u27a4 Telomerase</li><li>\u27a4 not responsible</li><li>\u27a4 repairing double-stranded DNA breaks</li><li>\u27a4 elongate telomeres</li><li>\u27a4 protective ends of chromosomes</li><li>\u27a4 RNA template</li><li>\u27a4 enzyme</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fc73c62b",
      "audio": ""
    },
    {
      "text": "Which of the following is associated with loss of function mutation in RET proto-oncogene?",
      "options": [
        {
          "label": "A",
          "text": "Medullary carcinoma of the thyroid",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pheochromocytoma",
          "correct": false
        },
        {
          "label": "C",
          "text": "Hirschsprung disease",
          "correct": true
        },
        {
          "label": "D",
          "text": "Pituitary adenoma",
          "correct": false
        }
      ],
      "correct_answer": "C. Hirschsprung disease",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Hirschsprung disease</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Options A and B: Gain of function mutations in RET proto-oncogene occurs in medullary thyroid carcinoma (Option A) and pheochromocytoma (Option B) as part of multiple endocrine neoplasia type 2A and 2B syndromes.</li><li>\u2022 Options A and B:</li><li>\u2022 Option D: Pituitary adenomas are typically associated with mutations in other genes such as MEN1 and are not directly linked to RET proto-oncogene mutations.</li><li>\u2022 Option D:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Loss of function mutation in the RET proto-oncogene is associated with Hirschsprung disease, which is characterized by the absence of ganglion cells in the distal colon, leading to functional intestinal obstruction.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3ca4a03f",
      "audio": ""
    },
    {
      "text": "Match the following:",
      "options": [
        {
          "label": "A",
          "text": "1-a, 2-b, 3-c",
          "correct": false
        },
        {
          "label": "B",
          "text": "1-c, 2-b, 3-a",
          "correct": false
        },
        {
          "label": "C",
          "text": "1-a, 2-c, 3-b",
          "correct": true
        },
        {
          "label": "D",
          "text": "1-b, 2-a, 3-c",
          "correct": false
        }
      ],
      "correct_answer": "C. 1-a, 2-c, 3-b",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/screenshot-2024-02-08-153127.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/18/screenshot-2024-06-18-131530.JPG"
      ],
      "explanation": "<p><strong>Ans. C) 1-a, 2-c, 3-b</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Ref : Robbins and Cotran pathologic basis of disease 10th edition page: 323</li><li>\u2022 Ref</li><li>\u2022 : Robbins and Cotran pathologic basis of disease 10th edition page: 323</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "27999353",
      "audio": ""
    },
    {
      "text": "Identify the false statement:",
      "options": [
        {
          "label": "A",
          "text": "Benzopyrene causes lung carcinoma",
          "correct": false
        },
        {
          "label": "B",
          "text": "Allen test is used to asses chemical Mutagenicity",
          "correct": true
        },
        {
          "label": "C",
          "text": "Indirect agents require Cytochrome P450 for conversion into carcinogen",
          "correct": false
        },
        {
          "label": "D",
          "text": "Chemical carcinogen converts salmonella into histidine positive type",
          "correct": false
        }
      ],
      "correct_answer": "B. Allen test is used to asses chemical Mutagenicity",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Allen test is used to asses chemical mutagenicity</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Benzo[a]pyrene , are formed during the high-temperature combustion of tobacco in cigarettes and are implicated in the causation of lung cancer.</li><li>\u2022 Option A.</li><li>\u2022 Benzo[a]pyrene</li><li>\u2022 high-temperature</li><li>\u2022 tobacco in cigarettes</li><li>\u2022 causation of lung cancer.</li><li>\u2022 Option C. Indirect-acting carcinogens require metabolic conversion to become active carcinogens by using cytochrome P-450\u2013dependent monooxygenases</li><li>\u2022 Option C.</li><li>\u2022 metabolic</li><li>\u2022 active carcinogens</li><li>\u2022 cytochrome P-450\u2013dependent monooxygenases</li><li>\u2022 Option D. The Ames test uses several strains of the bacterium Salmonella typhimurium that carry mutations in genes involved in histidine synthesis .</li><li>\u2022 Option D.</li><li>\u2022 Ames test</li><li>\u2022 several strains of the bacterium Salmonella typhimurium</li><li>\u2022 mutations in genes</li><li>\u2022 histidine synthesis</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Ames test checkss the capability of the tested substance in creating mutations that result in a return to a \"prototrophic \" state, so that the cells can grow on a histidine-free medium.</li><li>\u2022 Ames test</li><li>\u2022 capability of the tested substance</li><li>\u2022 mutations</li><li>\u2022 \"prototrophic</li><li>\u2022 cells can grow on a histidine-free medium.</li><li>\u2022 Ref : 1. Robbins and Cotran pathologic basis of disease 10th edition page: 322</li><li>\u2022 Ref : 1. Robbins and Cotran pathologic basis of disease 10th edition page: 322</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3a727d89",
      "audio": ""
    },
    {
      "text": "A 45-year-old patient with a history of chronic immunosuppression presents with cutaneous lesions and EBV infection. EBV is involved in the pathogenesis of all except:",
      "options": [
        {
          "label": "A",
          "text": "Hodgkin's Lymphoma",
          "correct": false
        },
        {
          "label": "B",
          "text": "Burkitt's lymphoma",
          "correct": false
        },
        {
          "label": "C",
          "text": "Nasopharyngeal Carcinoma",
          "correct": false
        },
        {
          "label": "D",
          "text": "Kaposi sarcoma",
          "correct": true
        }
      ],
      "correct_answer": "D. Kaposi sarcoma",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Kaposi sarcoma</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Hodgkin's Lymphoma : EBV is associated with a subset of Hodgkin's Lymphoma . In these cases, the virus is present in the malignant Reed-Sternberg cells and is thought to contribute to their formation .</li><li>\u2022 Option A. Hodgkin's Lymphoma :</li><li>\u2022 EBV</li><li>\u2022 subset of Hodgkin's Lymphoma</li><li>\u2022 virus</li><li>\u2022 malignant Reed-Sternberg cells</li><li>\u2022 contribute to their formation</li><li>\u2022 Option B. Burkitt's lymphoma: EBV is closely associated with Burkitt's lymphoma, especially the endemic variant found in malaria-prone regions of Africa. The virus is believed to drive the proliferation of B cells which, through additional genetic mutations, can develop into this aggressive form of lymphoma.</li><li>\u2022 Option B. Burkitt's lymphoma:</li><li>\u2022 EBV</li><li>\u2022 Burkitt's lymphoma,</li><li>\u2022 endemic variant</li><li>\u2022 malaria-prone regions of Africa.</li><li>\u2022 proliferation of B cells</li><li>\u2022 additional genetic mutations,</li><li>\u2022 aggressive form of lymphoma.</li><li>\u2022 Option C. Nasopharyngeal Carcinoma : EBV infection has been implicated in the development of nasopharyngeal carcinoma , particularly in populations where the cancer is endemic . The virus's DNA is often found in the malignant cells.</li><li>\u2022 Option C. Nasopharyngeal Carcinoma :</li><li>\u2022 EBV infection</li><li>\u2022 development of nasopharyngeal carcinoma</li><li>\u2022 cancer is endemic</li><li>\u2022 virus's DNA</li><li>\u2022 malignant cells.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Kaposi sarcoma is not associated with EBV but is caused by HHV-8 . While EBV is linked to various lymphomas and nasopharyngeal carcinoma , Kaposi sarcoma's pathogenesis involves a different herpesvirus.</li><li>\u27a4 Kaposi sarcoma</li><li>\u27a4 not</li><li>\u27a4 EBV</li><li>\u27a4 HHV-8</li><li>\u27a4 EBV is linked</li><li>\u27a4 lymphomas and nasopharyngeal carcinoma</li><li>\u27a4 Kaposi sarcoma's pathogenesis involves a different herpesvirus.</li><li>\u27a4 Ref : Robbins and Cotran pathologic basis of disease 10th edition page: 325-6</li><li>\u27a4 Ref</li><li>\u27a4 : Robbins and Cotran pathologic basis of disease 10th edition page: 325-6</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "601475db",
      "audio": ""
    },
    {
      "text": "Match the tumor with their biological carcinogens:",
      "options": [
        {
          "label": "A",
          "text": "1-d, 2-b, 3-a, 4-c",
          "correct": false
        },
        {
          "label": "B",
          "text": "1-d, 2-c, 3-a, 4-b",
          "correct": false
        },
        {
          "label": "C",
          "text": "1-b, 2-c, 3-d, 4-a",
          "correct": false
        },
        {
          "label": "D",
          "text": "1-b, 2-d, 3-a, 4-c",
          "correct": true
        }
      ],
      "correct_answer": "D. 1-b, 2-d, 3-a, 4-c",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/screenshot-2024-02-08-153832.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/screenshot-2024-02-08-153934.jpg"
      ],
      "explanation": "<p><strong>Ans. D) 1-b, 2-d, 3-a, 4-c</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "10352b1a",
      "audio": ""
    },
    {
      "text": "Match the paraneoplastic syndromes with associated neoplasm?",
      "options": [
        {
          "label": "A",
          "text": "1-a, 2-d, 3-c, 4-b",
          "correct": true
        },
        {
          "label": "B",
          "text": "1-b, 2-c, 3-d, 4-a",
          "correct": false
        },
        {
          "label": "C",
          "text": "1-c, 2-b, 3-a, 4-d",
          "correct": false
        },
        {
          "label": "D",
          "text": "1-d, 2-a, 3-b, 4-c",
          "correct": false
        }
      ],
      "correct_answer": "A. 1-a, 2-d, 3-c, 4-b",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/screenshot-2024-02-08-154023.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/screenshot-2024-02-08-154108.jpg"
      ],
      "explanation": "<p><strong>Ans. A) 1-a, 2-d, 3-c, 4-b</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Ref : Robbins and Cotran pathologic basis of disease 10th edition page: 329</li><li>\u2022 Ref</li><li>\u2022 : Robbins and Cotran pathologic basis of disease 10th edition page: 329</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fccf6141",
      "audio": ""
    },
    {
      "text": "Which of the following is false about Knudson's two-hit hypothesis theory on retinoblastoma?",
      "options": [
        {
          "label": "A",
          "text": "It involves both alleles of RB at chromosome locus 13q14",
          "correct": false
        },
        {
          "label": "B",
          "text": "In sporadic cases, both normal RB alleles must undergo somatic mutation in the same retinoblast",
          "correct": false
        },
        {
          "label": "C",
          "text": "Familial type is inherited as an autosomal recessive trait",
          "correct": true
        },
        {
          "label": "D",
          "text": "In familial cases, children inherit one defective copy of the RB gene and the other copy is normal",
          "correct": false
        }
      ],
      "correct_answer": "C. Familial type is inherited as an autosomal recessive trait",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Familial type is inherited as an autosomal recessive trait</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Knudson's hypothesis</li><li>\u2022 two-hit hypothesis or multiple-hit hypothesis states</li><li>\u2022 mutations in a cell's DNA</li><li>\u2022 Explanation:</li><li>\u2022 Option A. Two mutations (hits), involving both alleles of RB at chromosome locus 13q14, are required to produce retinoblastoma.</li><li>\u2022 Option A.</li><li>\u2022 Two mutations</li><li>\u2022 both alleles of RB at chromosome locus 13q14,</li><li>\u2022 retinoblastoma.</li><li>\u2022 Option B. In sporadic cases , both normal RB alleles must undergo somatic mutation in the same retinoblast (two hits).</li><li>\u2022 Option B.</li><li>\u2022 In sporadic cases</li><li>\u2022 RB alleles</li><li>\u2022 somatic mutation</li><li>\u2022 Option D. In familial cases, children inherit one defective copy of the RB gene in the germline (the first hit), and the other copy is normal. Retinoblastoma develops when the normal RB allele is mutated in retinoblasts as a result of a spontaneous somatic mutation (the second hit).</li><li>\u2022 Option D.</li><li>\u2022 defective copy of the RB gene in the germline (the first hit),</li><li>\u2022 Retinoblastoma</li><li>\u2022 normal RB allele</li><li>\u2022 mutated in retinoblasts</li><li>\u2022 spontaneous somatic mutation (the second hit).</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Familial retinoblastoma is inherited in an autosomal dominant pattern, not autosomal recessive. According to Knudson's two-hit hypothesis , a single inherited mutation in one allele of the RB gene is sufficient to predispose to retinoblastoma , but a second somatic mutation in the other allele must occur for the cancer to develop .</li><li>\u27a4 Familial retinoblastoma</li><li>\u27a4 an autosomal dominant pattern,</li><li>\u27a4 Knudson's two-hit hypothesis</li><li>\u27a4 single inherited mutation</li><li>\u27a4 one allele of the RB gene</li><li>\u27a4 retinoblastoma</li><li>\u27a4 a second somatic mutation</li><li>\u27a4 other allele</li><li>\u27a4 cancer to develop</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4dc518a5",
      "audio": ""
    },
    {
      "text": "Match the Immuno- markers with its associated neoplasm:",
      "options": [
        {
          "label": "A",
          "text": "1-c, 2-a, 3-d, 4-b",
          "correct": false
        },
        {
          "label": "B",
          "text": "1-c, 2-d, 3-b, 4-a",
          "correct": false
        },
        {
          "label": "C",
          "text": "1-c, 2-b, 3-a, 4-d",
          "correct": false
        },
        {
          "label": "D",
          "text": "1-b, 2-c, 3-d, 4-a",
          "correct": true
        }
      ],
      "correct_answer": "D. 1-b, 2-c, 3-d, 4-a",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/screenshot-2024-02-08-154335.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/25/screenshot-2024-04-25-123409.png"
      ],
      "explanation": "<p><strong>Ans. D) 1-b, 2-c, 3-d, 4-a</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Ref : Robbins and Cotran pathologic basis of disease 10th edition page: 270</li><li>\u2022 Ref</li><li>\u2022 : Robbins and Cotran pathologic basis of disease 10th edition page: 270</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "21c87057",
      "audio": ""
    },
    {
      "text": "A physician is considering the differential diagnoses for a patient's elevated serum tumor marker levels. Carcinoembryonic antigen (CEA) is known to be elevated in various malignancies and benign conditions. Which of the following conditions is NOT typically associated with an elevated CEA level?",
      "options": [
        {
          "label": "A",
          "text": "Alcoholic cirrhosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Carcinoma colon",
          "correct": false
        },
        {
          "label": "C",
          "text": "Carcinoma prostate",
          "correct": true
        },
        {
          "label": "D",
          "text": "Emphysema",
          "correct": false
        }
      ],
      "correct_answer": "C. Carcinoma prostate",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/screenshot-2024-02-08-154619.jpg"
      ],
      "explanation": "<p><strong>Ans. C) Carcinoma prostate</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Alcoholic cirrhosis Alcoholic cirrhosis can lead to elevated CEA levels. CEA is not specific for malignancy and can be raised in a variety of benign liver conditions, including cirrhosis, especially when related to alcohol use .</li><li>\u2022 Option A. Alcoholic cirrhosis</li><li>\u2022 elevated CEA levels.</li><li>\u2022 not specific</li><li>\u2022 malignancy</li><li>\u2022 benign liver conditions, including cirrhosis,</li><li>\u2022 alcohol use</li><li>\u2022 Option B. Carcinoma of the colon CEA levels are frequently elevated in colorectal cancer and can be used as a marker for monitoring treatment response or disease recurrence after the removal of the primary tumor .</li><li>\u2022 Option B. Carcinoma of the colon</li><li>\u2022 CEA</li><li>\u2022 elevated</li><li>\u2022 colorectal cancer</li><li>\u2022 treatment response or disease</li><li>\u2022 primary tumor</li><li>\u2022 Option D. Emphysema Chronic lung conditions, including emphysema, can also result in elevated CEA levels , even though these are not malignant conditions. Smoking, which is a risk factor for emphysema , can itself cause elevated CEA levels.</li><li>\u2022 Option D. Emphysema</li><li>\u2022 elevated CEA levels</li><li>\u2022 not malignant conditions. Smoking,</li><li>\u2022 risk factor</li><li>\u2022 emphysema</li><li>\u2022 elevated CEA levels.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Carcinoma of the prostate , is not associated with elevated CEA levels . Instead, prostate-specific antigen (PSA) is the tumor marker commonly elevated in prostate cancer . CEA is used primarily for monitoring colorectal cancer and can be elevated in various benign conditions , including liver and lung diseases .</li><li>\u27a4 Carcinoma of the prostate</li><li>\u27a4 not</li><li>\u27a4 elevated CEA levels</li><li>\u27a4 prostate-specific antigen (PSA)</li><li>\u27a4 tumor marker</li><li>\u27a4 prostate cancer</li><li>\u27a4 CEA</li><li>\u27a4 monitoring colorectal cancer</li><li>\u27a4 elevated</li><li>\u27a4 benign conditions</li><li>\u27a4 liver and lung diseases</li><li>\u27a4 Ref : Robbins and Cotran pathologic basis of disease 10th edition page: 336</li><li>\u27a4 Ref</li><li>\u27a4 : Robbins and Cotran pathologic basis of disease 10th edition page: 336</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "881a6758",
      "audio": ""
    },
    {
      "text": "Most common carcinoma associated with inferior vena cava metastasis?",
      "options": [
        {
          "label": "A",
          "text": "Small cell carcinoma lung",
          "correct": false
        },
        {
          "label": "B",
          "text": "Gastric adenocarcinoma",
          "correct": false
        },
        {
          "label": "C",
          "text": "Renal cell carcinoma",
          "correct": true
        },
        {
          "label": "D",
          "text": "Papillary carcinoma thyroid",
          "correct": false
        }
      ],
      "correct_answer": "C. Renal cell carcinoma",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Renal cell carcinoma</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: Small cell carcinoma of the lung While lung cancers can invade vascular structures, small cell carcinoma of the lung more commonly involves the superior vena cava (SVC), leading to SVC syndrome, rather than the IVC.</li><li>\u2022 Option A: Small cell carcinoma of the lung</li><li>\u2022 lung cancers</li><li>\u2022 vascular structures, small cell carcinoma of the lung</li><li>\u2022 superior vena cava (SVC),</li><li>\u2022 SVC syndrome,</li><li>\u2022 Option B: Gastric adenocarcinoma Gastric adenocarcinoma typically metastasizes to the liver, peritoneum, and lymph nodes . Direct invasion into the IVC is rare with gastric cancers.</li><li>\u2022 Option B: Gastric adenocarcinoma</li><li>\u2022 metastasizes to the liver, peritoneum, and lymph nodes</li><li>\u2022 invasion into the IVC</li><li>\u2022 Option D: Papillary carcinoma of the thyroid : Thyroid cancers, including papillary carcinoma, primarily spread to regional neck lymph nodes and, less commonly , to distant sites . Direct IVC invasion is not characteristic of thyroid carcinomas .</li><li>\u2022 Option D: Papillary carcinoma of the thyroid :</li><li>\u2022 papillary carcinoma,</li><li>\u2022 regional neck lymph nodes</li><li>\u2022 less commonly</li><li>\u2022 distant sites</li><li>\u2022 Direct IVC invasion</li><li>\u2022 thyroid carcinomas</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Renal cell carcinoma is the carcinoma most commonly associated with metastasis to the inferior vena cava . This type of tumor can grow within the kidney's collecting system and extend into the renal vein and then into the IVC .</li><li>\u27a4 Renal cell carcinoma</li><li>\u27a4 metastasis to the inferior vena cava</li><li>\u27a4 grow within the kidney's collecting system</li><li>\u27a4 extend into the renal vein</li><li>\u27a4 IVC</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "39f91b0a",
      "audio": ""
    },
    {
      "text": "A 78-year-old Navy veteran with a smoking habit of 600 packs per year is diagnosed with cancer. During his military career, he was involved in the use of asbestos insulation to fireproof naval combat ships. Which cancer do both smoke and asbestos contribute to, given his environmental exposure to both?",
      "options": [
        {
          "label": "A",
          "text": "Bladder cancer",
          "correct": false
        },
        {
          "label": "B",
          "text": "Lung cancer",
          "correct": true
        },
        {
          "label": "C",
          "text": "Cancer of the throat",
          "correct": false
        },
        {
          "label": "D",
          "text": "Esophageal cancer",
          "correct": false
        }
      ],
      "correct_answer": "B. Lung cancer",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Lung cancer</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Bladder cancer Tobacco smoking is a well-known risk factor for bladder cancer due to the systemic absorption of carcinogens present in smoke . However, asbestos exposure is not typically associated with bladder cancer .</li><li>\u2022 Option A. Bladder cancer</li><li>\u2022 Tobacco smoking</li><li>\u2022 well-known risk factor</li><li>\u2022 due</li><li>\u2022 systemic absorption of carcinogens</li><li>\u2022 smoke</li><li>\u2022 asbestos exposure</li><li>\u2022 not</li><li>\u2022 bladder cancer</li><li>\u2022 Option C. Cancer of the throat While smoking is a risk factor for throat cancer, including cancers of the larynx and pharynx , asbestos has not been as strongly linked to throat cancer compared to lung cancer.</li><li>\u2022 Option C. Cancer of the throat</li><li>\u2022 smoking is a risk factor</li><li>\u2022 throat cancer,</li><li>\u2022 larynx and pharynx</li><li>\u2022 asbestos has not</li><li>\u2022 throat cancer compared to lung cancer.</li><li>\u2022 Option D. Esophageal cancer: Smoking is also a risk factor for esophageal cancer , but asbestos exposure is more specifically associated with lung cancer and mesothelioma rather than esophageal cancer .</li><li>\u2022 Option D. Esophageal cancer:</li><li>\u2022 Smoking</li><li>\u2022 risk factor for esophageal cancer</li><li>\u2022 asbestos exposure</li><li>\u2022 more</li><li>\u2022 lung cancer and mesothelioma</li><li>\u2022 esophageal cancer</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Both cigarette smoke and asbestos are significant risk factors for lung cancer , and their combined exposure greatly increases the risk , even more so than exposure to either risk factor alone .</li><li>\u27a4 Both cigarette smoke and asbestos</li><li>\u27a4 risk factors for lung cancer</li><li>\u27a4 increases the risk</li><li>\u27a4 more</li><li>\u27a4 either risk factor alone</li><li>\u27a4 Ref : Robbins and Cotran pathologic basis of disease 10th edition page: 321</li><li>\u27a4 Ref</li><li>\u27a4 : Robbins and Cotran pathologic basis of disease 10th edition page: 321</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "abfece07",
      "audio": ""
    },
    {
      "text": "A 40-year-old woman presents with endometrial carcinoma. Her mother died of endometrial cancer when she was 50, and her 42-year-old brother was recently diagnosed with colon cancer. You begin to suspect a familial cancer syndrome. Which gene in this family is most likely to be mutated?",
      "options": [
        {
          "label": "A",
          "text": "WT-1",
          "correct": false
        },
        {
          "label": "B",
          "text": "APC",
          "correct": false
        },
        {
          "label": "C",
          "text": "MSH2",
          "correct": true
        },
        {
          "label": "D",
          "text": "p53",
          "correct": false
        }
      ],
      "correct_answer": "C. MSH2",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) MSH2</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. WT-1 mutations predispose patients to Wilms tumors.</li><li>\u2022 Option A.</li><li>\u2022 WT-1 mutations</li><li>\u2022 Wilms tumors.</li><li>\u2022 Option B. APC is mutated in familial adenomatous polyposis (FAP).</li><li>\u2022 Option B.</li><li>\u2022 APC</li><li>\u2022 familial adenomatous polyposis (FAP).</li><li>\u2022 Option D. Germline mutations in p53 are seen in Li Fraumeni syndrome.</li><li>\u2022 Option D.</li><li>\u2022 Germline mutations</li><li>\u2022 p53</li><li>\u2022 Li Fraumeni syndrome.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 This family likely has Lynch syndrome (Hereditary Non-Polyposis Colorectal Cancer, HNPCC), associated with mutations in DNA mismatch repair genes such as MSH2 , often presenting with gynecological malignancies before colorectal tumors.</li><li>\u27a4 family</li><li>\u27a4 Lynch syndrome (Hereditary Non-Polyposis Colorectal Cancer, HNPCC),</li><li>\u27a4 mutations in DNA mismatch repair genes</li><li>\u27a4 MSH2</li><li>\u27a4 gynecological malignancies before colorectal tumors.</li><li>\u27a4 Ref : Robbins and Cotran pathologic basis of disease 10th edition page:314</li><li>\u27a4 Ref</li><li>\u27a4 : Robbins and Cotran pathologic basis of disease 10th edition page:314</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "977f3bb3",
      "audio": ""
    },
    {
      "text": "A 25-year-old female with a strong family history of various cancers is being evaluated for genetic predisposition. Understanding the role of tumor suppressor genes, particularly p53, is crucial for her assessment. Which of the following statements about the function of p53 is incorrect?",
      "options": [
        {
          "label": "A",
          "text": "It regulates cellular senescence",
          "correct": false
        },
        {
          "label": "B",
          "text": "P53 inactivation causes cell cycle arrest at G2-M",
          "correct": true
        },
        {
          "label": "C",
          "text": "Cancers demonstrate biallelic loss of function mutations in TP53",
          "correct": false
        },
        {
          "label": "D",
          "text": "p53 can be inactivated by E6 protein of HPV",
          "correct": false
        }
      ],
      "correct_answer": "B. P53 inactivation causes cell cycle arrest at G2-M",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) P53 inactivation causes cell cycle arrest at G2-M</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. It regulates cellular senescence. This is true . p53 plays a role in halting cell proliferation when cells become old (senescent), potentially preventing the replication of damaged DNA .</li><li>\u2022 Option A. It regulates cellular senescence.</li><li>\u2022 true</li><li>\u2022 p53</li><li>\u2022 halting cell proliferation</li><li>\u2022 cells</li><li>\u2022 (senescent),</li><li>\u2022 replication of damaged DNA</li><li>\u2022 Option C. Cancers often exhibit biallelic loss of function mutations in TP53. True. Many cancers demonstrate loss of function in both alleles of the TP53 gene, which encodes th e p53 protein , leading to unregulated cell growth.</li><li>\u2022 Option C. Cancers often exhibit biallelic loss of function mutations in TP53.</li><li>\u2022 True.</li><li>\u2022 loss of function</li><li>\u2022 both alleles of the TP53 gene,</li><li>\u2022 e p53 protein</li><li>\u2022 unregulated cell growth.</li><li>\u2022 Option D. p53 can be inactivated by the E6 protein of HPV. This is true. Human papillomavirus (HPV) can lead to cancer development through its E6 protein , which inactivates p53, thereby preventing it from performing its tumor suppressor functions.</li><li>\u2022 Option D. p53 can be inactivated by the E6 protein of HPV.</li><li>\u2022 true. Human papillomavirus (HPV)</li><li>\u2022 E6 protein</li><li>\u2022 inactivates p53,</li><li>\u2022 preventing</li><li>\u2022 tumor suppressor functions.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 p53 inactivation does not cause cell cycle arrest at the G2-M checkpoint . Activation of p53 leads to cell cycle arrest , allowing time for DNA repair or triggering apoptosis if the damage is irreparable . This function is critical in preventing the proliferation of cells with genetic damage.</li><li>\u27a4 p53 inactivation does not</li><li>\u27a4 cell cycle arrest at the G2-M checkpoint</li><li>\u27a4 Activation of p53</li><li>\u27a4 cell cycle arrest</li><li>\u27a4 DNA repair or triggering apoptosis</li><li>\u27a4 irreparable</li><li>\u27a4 proliferation of cells with genetic damage.</li><li>\u27a4 Ref : Robbins and Cotran pathologic basis of disease 10th edition page:296</li><li>\u27a4 Ref</li><li>\u27a4 : Robbins and Cotran pathologic basis of disease 10th edition page:296</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "68f2bfd6",
      "audio": ""
    },
    {
      "text": "A 25-year-old man presents with anemia and abdominal pain. On examination, he has pigmented macules over the palms, soles, and oral mucosa. Further investigations reveal loss-of-function mutations of the STK11 gene. What is the most probable diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "HNPCC",
          "correct": false
        },
        {
          "label": "B",
          "text": "Gorlin syndrome",
          "correct": false
        },
        {
          "label": "C",
          "text": "Von Hipplel - Lindau syndrome",
          "correct": false
        },
        {
          "label": "D",
          "text": "Peutz Jeghers syndrome",
          "correct": true
        }
      ],
      "correct_answer": "D. Peutz Jeghers syndrome",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Peutz Jeghers syndrome</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. HNPCC: HNPCC, also known as Lynch syndrome , is an autosomal dominant condition predisposing individuals to early-onset colorectal cancer and other malignancies . It is associated with mutations in mismatch repair genes, not STK11.</li><li>\u2022 Option A. HNPCC:</li><li>\u2022 Lynch syndrome</li><li>\u2022 autosomal dominant condition</li><li>\u2022 early-onset colorectal cancer and other malignancies</li><li>\u2022 mutations in mismatch repair genes,</li><li>\u2022 Option B. Gorlin syndrome: Gorlin syndrome, or nevoid basal cell carcinoma syndrome , is characterized by multiple basal cell carcinomas, odontogenic keratocysts, and skeletal anomalies . It is associated with mutations in the PTCH1 gene , not STK11.</li><li>\u2022 Option B. Gorlin syndrome:</li><li>\u2022 nevoid basal cell carcinoma syndrome</li><li>\u2022 multiple basal cell carcinomas, odontogenic keratocysts, and skeletal anomalies</li><li>\u2022 mutations in the PTCH1 gene</li><li>\u2022 Option C. Von Hippel-Lindau syndrome: Von Hippel-Lindau syndrome is a hereditary cancer syndrome associated with a variety of tumors, including hemangioblastomas, clear cell renal cell carcinoma, and pheochromocytomas. It is related to mutations in the VHL gene .</li><li>\u2022 Option C. Von Hippel-Lindau syndrome:</li><li>\u2022 Von Hippel-Lindau syndrome</li><li>\u2022 hereditary cancer</li><li>\u2022 hemangioblastomas, clear cell renal cell carcinoma, and pheochromocytomas.</li><li>\u2022 VHL gene</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Peutz-Jeghers syndrome is an autosomal dominant disorder associated with gastrointestinal polyps and mucocutaneous pigmentation, due to mutations in the STK11 gene , and it elevates the risk of multiple cancers .</li><li>\u27a4 Peutz-Jeghers syndrome</li><li>\u27a4 autosomal dominant disorder</li><li>\u27a4 gastrointestinal polyps and mucocutaneous pigmentation,</li><li>\u27a4 STK11 gene</li><li>\u27a4 risk of multiple cancers</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fbec7565",
      "audio": ""
    },
    {
      "text": "Which of the following mechanisms does not lead to immune evasion by the tumor cells?",
      "options": [
        {
          "label": "A",
          "text": "Inhibition of PD1 receptor on T-cells",
          "correct": true
        },
        {
          "label": "B",
          "text": "Upregulation of expression of PDL1",
          "correct": false
        },
        {
          "label": "C",
          "text": "Induction of galectin",
          "correct": false
        },
        {
          "label": "D",
          "text": "Induction of regulatory T-cells",
          "correct": false
        }
      ],
      "correct_answer": "A. Inhibition of PD1 receptor on T-cells",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Inhibition of PD1 receptor on T-cells</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Upregulation of expression of PDL1: Tumor cells often upregulate PD-L1, which binds to the PD1 receptor on T cells, leading to the inhibition of the immune response against the tumor, effectively allowing the tumor to evade the immune system.</li><li>\u2022 Option B. Upregulation of expression of PDL1:</li><li>\u2022 Tumor cells often upregulate PD-L1,</li><li>\u2022 PD1 receptor on T cells,</li><li>\u2022 inhibition of the immune response</li><li>\u2022 tumor,</li><li>\u2022 tumor to evade the immune system.</li><li>\u2022 Option C. Induction of galectin Tumor cells can induce galectins, which are beta-galactoside-binding proteins that can negatively regulate T-cell apoptosis , affect T-cell receptor signaling, or contribute to the creation of an immunosuppressive tumor microenvironment, facilitating immune evasion .</li><li>\u2022 Option C. Induction of galectin</li><li>\u2022 galectins,</li><li>\u2022 beta-galactoside-binding proteins</li><li>\u2022 negatively regulate T-cell apoptosis</li><li>\u2022 T-cell receptor signaling,</li><li>\u2022 immunosuppressive tumor microenvironment, facilitating immune evasion</li><li>\u2022 ; Option D. Induction of regulatory T-cells: Tumors may induce regulatory T cells (Tregs), which suppress the activation of the immune system and maintain tolerance to self-antigens, thus aiding in tumor immune evasion.</li><li>\u2022 Option D. Induction of regulatory T-cells:</li><li>\u2022 Tumors</li><li>\u2022 regulatory T cells (Tregs),</li><li>\u2022 tolerance to self-antigens,</li><li>\u2022 tumor immune evasion.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Inhibition of the PD1 receptor on T cells does not lead to immune evasion by tumor cells; rather, it activates the immune response against the tumor. PD1 receptor inhibition is a strategy used in cancer immunotherapy to overcome tumor-induced immune suppression.</li><li>\u27a4 Inhibition of the PD1 receptor on T cells does not</li><li>\u27a4 immune evasion</li><li>\u27a4 activates the immune response</li><li>\u27a4 tumor. PD1 receptor</li><li>\u27a4 cancer immunotherapy</li><li>\u27a4 tumor-induced immune</li><li>\u27a4 suppression.</li><li>\u27a4 Ref : Robbins and Cotran pathologic basis of disease 10th edition page: 312</li><li>\u27a4 Ref</li><li>\u27a4 : Robbins and Cotran pathologic basis of disease 10th edition page: 312</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fac0a49a",
      "audio": ""
    },
    {
      "text": "A dermatology resident is reviewing cases of skin cancer to understand the etiological role of different types of ultraviolet (UV) radiation. Which type of UV radiation is primarily responsible for the development of cutaneous cancers through the formation of DNA damage?",
      "options": [
        {
          "label": "A",
          "text": "Only UVA",
          "correct": false
        },
        {
          "label": "B",
          "text": "Only UVB",
          "correct": true
        },
        {
          "label": "C",
          "text": "Both UVB and UVC",
          "correct": false
        },
        {
          "label": "D",
          "text": "Both UVA and UVC",
          "correct": false
        }
      ],
      "correct_answer": "B. Only UVB",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/25/screenshot-2024-04-25-125100.png"
      ],
      "explanation": "<p><strong>Ans. B) Only UVB</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Only UVA: UVA radiation contributes to skin aging and can penetrate more deeply into the skin , but it is less effective than UVB at causing the direct DNA damage that leads to cutaneous cancers .</li><li>\u2022 Option A. Only UVA:</li><li>\u2022 skin aging</li><li>\u2022 deeply into the skin</li><li>\u2022 less effective</li><li>\u2022 UVB at causing the direct DNA damage</li><li>\u2022 cutaneous cancers</li><li>\u2022 Option C. Both UVB and UVC: While UVB does cause cutaneous cancers , UVC is mostly absorbed by the ozone layer and does not reach the Earth's surface to affect skin . Therefore, in the natural environment, UVC does not contribute to skin cancers .</li><li>\u2022 Option C. Both UVB and UVC:</li><li>\u2022 UVB does cause cutaneous cancers</li><li>\u2022 UVC</li><li>\u2022 absorbed by the ozone layer</li><li>\u2022 does not reach the Earth's surface to affect skin</li><li>\u2022 natural environment, UVC does not contribute to skin cancers</li><li>\u2022 Option D. Both UVA and UVC: Although UVA can contribute to DNA damage indirectly through the generation of reactive oxygen species, it is primarily UVB, not UVC, that is associated with the direct DNA damage causing cutaneous cancers.</li><li>\u2022 Option D. Both UVA and UVC:</li><li>\u2022 UVA can contribute to DNA damage</li><li>\u2022 reactive oxygen</li><li>\u2022 it is primarily UVB,</li><li>\u2022 direct DNA damage causing cutaneous cancers.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 UVB is the form of ultraviolet radiation primarily responsible for causing cutaneous cancers due to its ability to induce the formation of pyrimidine dimers in DNA.</li><li>\u27a4 UVB</li><li>\u27a4 ultraviolet radiation</li><li>\u27a4 cutaneous cancers</li><li>\u27a4 induce</li><li>\u27a4 pyrimidine dimers in DNA.</li><li>\u27a4 UV portion of the solar spectrum is divided into three wavelength ranges :</li><li>\u27a4 UV portion</li><li>\u27a4 solar spectrum</li><li>\u27a4 three wavelength ranges</li><li>\u27a4 Ref : \u200b\u200b https://www.cancer.org/healthy/cancer-causes/radiation-exposure/uv-radiation.html</li><li>\u27a4 Ref : \u200b\u200b</li><li>\u27a4 https://www.cancer.org/healthy/cancer-causes/radiation-exposure/uv-radiation.html</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1380963a",
      "audio": ""
    },
    {
      "text": "Which of the following malignancies is caused by HTLV-1?",
      "options": [
        {
          "label": "A",
          "text": "Enteropathy associated T-cell lymphoma",
          "correct": false
        },
        {
          "label": "B",
          "text": "Adult T-cell leukemia/ lymphoma",
          "correct": true
        },
        {
          "label": "C",
          "text": "Diffuse large B cell lymphoma",
          "correct": false
        },
        {
          "label": "D",
          "text": "B cell lymphomas",
          "correct": false
        }
      ],
      "correct_answer": "B. Adult T-cell leukemia/ lymphoma",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Adult T-cell leukemia/ lymphoma</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Human T-cell leukemia-lymphoma virus (HTLV-1) causes adult T-cell leukemia/lymphoma (ATLL). HTLV-1 encodes the viral protein Tax , which leads to polyclonal expansion of T cells. It exhibits tropism for CD4+ T cells. Human infection requires transmission of infected T cells through sexual intercourse, blood products or breast feeding. Leukemia develops only in 3-5% of infected individuals , typically after a long latent period of 40-60 years .</li><li>\u2022 Human T-cell leukemia-lymphoma virus (HTLV-1) causes adult T-cell leukemia/lymphoma (ATLL).</li><li>\u2022 Human T-cell leukemia-lymphoma virus (HTLV-1)</li><li>\u2022 adult T-cell leukemia/lymphoma (ATLL).</li><li>\u2022 HTLV-1 encodes the viral protein Tax , which leads to polyclonal expansion of T cells. It exhibits tropism for CD4+ T cells.</li><li>\u2022 viral protein Tax</li><li>\u2022 polyclonal expansion of T cells.</li><li>\u2022 tropism for CD4+ T cells.</li><li>\u2022 Human infection requires transmission of infected T cells through sexual intercourse, blood products or breast feeding.</li><li>\u2022 transmission of infected T cells through sexual intercourse, blood products or breast feeding.</li><li>\u2022 Leukemia develops only in 3-5% of infected individuals , typically after a long latent period of 40-60 years .</li><li>\u2022 3-5% of infected individuals</li><li>\u2022 long latent period of 40-60 years</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 The malignancy caused by HTLV-1 is Adult T-cell leukemia/lymphoma (ATLL), which is marked by a proliferation of CD4+ T cells. Transmission of HTLV-1 occurs through sexual contact, blood products, or breast feeding, and the development of leukemia is rare , affecting only a small percentage of those infected after a long latency period .</li><li>\u2022 HTLV-1 is Adult T-cell leukemia/lymphoma (ATLL),</li><li>\u2022 proliferation of CD4+ T cells.</li><li>\u2022 sexual contact, blood products, or breast feeding,</li><li>\u2022 leukemia is rare</li><li>\u2022 infected after a long latency period</li><li>\u2022 Ref : Robbins and Cotran pathologic basis of disease 10th edition page: 324,5,6</li><li>\u2022 Ref</li><li>\u2022 : Robbins and Cotran pathologic basis of disease 10th edition page: 324,5,6</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d8b50987",
      "audio": ""
    },
    {
      "text": "A 30-year-old male presents with fever, sore throat, and lymphadenopathy. Serological tests are positive for Epstein-Barr virus (EBV) infection. Which of the following statements about the pathophysiology of EBV is incorrect?",
      "options": [
        {
          "label": "A",
          "text": "It uses the complement receptor CD21 to attach and infect B cells",
          "correct": false
        },
        {
          "label": "B",
          "text": "It is implicated in B-cell lymphomas in immunosuppressed people",
          "correct": false
        },
        {
          "label": "C",
          "text": "It is a potent inducer of B-cell growth and transformation",
          "correct": false
        },
        {
          "label": "D",
          "text": "EBV infection always results in Burkitt lymphoma",
          "correct": true
        }
      ],
      "correct_answer": "D. EBV infection always results in Burkitt lymphoma",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) EBV infection always results in Burkitt lymphoma</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. It uses the complement receptor CD21 to attach and infect B cells. This is correct. EBV uses the CD21 receptor , which is the complement receptor on B cells, to infect them .</li><li>\u2022 Option A. It uses the complement receptor CD21 to attach and infect B cells.</li><li>\u2022 correct. EBV</li><li>\u2022 CD21 receptor</li><li>\u2022 complement receptor on B cells, to infect them</li><li>\u2022 Option B. It is implicated in B-cell lymphomas in individuals with immunosuppression. True. EBV is associated with various B-cell lymphomas, especially in individuals who are immunosuppressed, such as those with HIV or post-transplant patients.</li><li>\u2022 Option B. It is implicated in B-cell lymphomas in individuals with immunosuppression.</li><li>\u2022 True. EBV</li><li>\u2022 B-cell lymphomas,</li><li>\u2022 immunosuppressed,</li><li>\u2022 HIV or post-transplant patients.</li><li>\u2022 Option C. It is a potent inducer of B-cell growth and transformation. This is correct. EBV can drive B-cell growth and transformation , contributing to the development of diseases like infectious mononucleosis and , in some cases, B-cell lymphomas.</li><li>\u2022 Option C. It is a potent inducer of B-cell growth and transformation.</li><li>\u2022 correct. EBV</li><li>\u2022 B-cell growth and transformation</li><li>\u2022 infectious mononucleosis and</li><li>\u2022 B-cell lymphomas.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 EBV infection does not always lead to Burkitt lymphoma . While EBV can infect B cells and is associated with various lymphomas, the outcome of infection ranges from asymptomatic to infectious mononucleosis, with only a minority progressing to Burkitt lymphoma or other types of B-cell lymphoma.</li><li>\u27a4 EBV infection does not</li><li>\u27a4 Burkitt lymphoma</li><li>\u27a4 EBV</li><li>\u27a4 B cells</li><li>\u27a4 various lymphomas,</li><li>\u27a4 asymptomatic to infectious mononucleosis,</li><li>\u27a4 minority progressing to Burkitt lymphoma</li><li>\u27a4 B-cell lymphoma.</li><li>\u27a4 Ref : Robbins and Cotran pathologic basis of disease 10th edition page: 326</li><li>\u27a4 Ref : Robbins and Cotran pathologic basis of disease 10th edition page: 326</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1abbd325",
      "audio": ""
    },
    {
      "text": "A 60-year-old patient presents with loss of weight and appetite. On clinical examination, grade IV clubbing is evident. Imaging shows periosteal new bone formation and left knee joint effusion. Which of the following tumors is associated with this condition?",
      "options": [
        {
          "label": "A",
          "text": "Bronchogenic carcinoma",
          "correct": true
        },
        {
          "label": "B",
          "text": "Carcinoma of the pancreas",
          "correct": false
        },
        {
          "label": "C",
          "text": "Esophageal carcinoma",
          "correct": false
        },
        {
          "label": "D",
          "text": "Acute myeloid leukemia",
          "correct": false
        }
      ],
      "correct_answer": "A. Bronchogenic carcinoma",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Bronchogenic carcinoma</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Carcinoma of the pancreas: While patients with pancreatic cancer may develop paraneoplastic syndromes, hypertrophic osteoarthropathy is not typically associated with this type of malignancy.</li><li>\u2022 Option B. Carcinoma of the pancreas:</li><li>\u2022 paraneoplastic syndromes, hypertrophic osteoarthropathy</li><li>\u2022 not</li><li>\u2022 type of malignancy.</li><li>\u2022 Option C. Esophageal carcinoma: Esophageal carcinoma can be associated with paraneoplastic phenomena including clubbing , but it is less commonly associated with hypertrophic osteoarthropathy compared to bronchogenic carcinoma.</li><li>\u2022 Option C. Esophageal carcinoma:</li><li>\u2022 Esophageal carcinoma</li><li>\u2022 paraneoplastic phenomena</li><li>\u2022 clubbing</li><li>\u2022 less</li><li>\u2022 hypertrophic osteoarthropathy</li><li>\u2022 Option D. Acute myeloid leukemia: Hematologic malignancies like AML are not commonly associated with hypertrophic osteoarthropathy . Paraneoplastic syndromes are more commonly associated with solid tumors.</li><li>\u2022 Option D. Acute myeloid leukemia:</li><li>\u2022 Hematologic</li><li>\u2022 AML</li><li>\u2022 not</li><li>\u2022 hypertrophic osteoarthropathy</li><li>\u2022 Paraneoplastic syndromes</li><li>\u2022 solid tumors.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Hypertrophic osteoarthropathy is characterized by the following:</li><li>\u27a4 Hypertrophic osteoarthropathy</li><li>\u27a4 Periosteal new bone formation , primarily at the distal ends of long bones, metatarsals, metacarpals, and proximal phalanges Arthritis of the adjacent joints Clubbing of the digits</li><li>\u27a4 Periosteal new bone formation , primarily at the distal ends of long bones, metatarsals, metacarpals, and proximal phalanges</li><li>\u27a4 Periosteal new bone formation</li><li>\u27a4 distal ends of long bones, metatarsals, metacarpals, and proximal phalanges</li><li>\u27a4 Arthritis of the adjacent joints</li><li>\u27a4 Arthritis of the adjacent joints</li><li>\u27a4 Clubbing of the digits</li><li>\u27a4 Clubbing of the digits</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "93ffddf3",
      "audio": ""
    },
    {
      "text": "A 55-year-old patient presents with generalized tiredness, malaise, muscle weakness, and bone pain. Laboratory investigations reveal serum calcium to be 13 mg/dL. Which of the following lung cancers is implicated in this patient?",
      "options": [
        {
          "label": "A",
          "text": "Small cell carcinoma of lung",
          "correct": false
        },
        {
          "label": "B",
          "text": "Adenosquamous carcinoma of lung",
          "correct": false
        },
        {
          "label": "C",
          "text": "Squamous cell carcinoma of lung",
          "correct": true
        },
        {
          "label": "D",
          "text": "Large cell carcinoma of lung",
          "correct": false
        }
      ],
      "correct_answer": "C. Squamous cell carcinoma of lung",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Squamous cell carcinoma of lung</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Small cell carcinoma of the lung: Small cell carcinoma of the lung is more commonly associated with paraneoplastic syndromes like SIADH or Cushing's syndrome due to ectopic ACTH production, rather than hypercalcemia.</li><li>\u2022 Option A. Small cell carcinoma of the lung:</li><li>\u2022 more</li><li>\u2022 paraneoplastic syndromes like SIADH or Cushing's syndrome</li><li>\u2022 ectopic ACTH production,</li><li>\u2022 hypercalcemia.</li><li>\u2022 Option B. Adenosquamous carcinoma of the lung: Adenosquamous carcinoma of the lung can produce paraneoplastic syndromes , but it is not the most common type associated with hypercalcemia.</li><li>\u2022 Option B. Adenosquamous carcinoma of the lung:</li><li>\u2022 paraneoplastic syndromes</li><li>\u2022 not</li><li>\u2022 hypercalcemia.</li><li>\u2022 Option D. Large cell carcinoma of the lung: Large cell carcinoma can present with several paraneoplastic syndromes , but it is not the most frequent cause of paraneoplastic hypercalcemia.</li><li>\u2022 Option D. Large cell carcinoma of the lung:</li><li>\u2022 several paraneoplastic syndromes</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Squamous cell carcinoma of the lung is frequently associated with paraneoplastic hypercalcemia, often due to the secretion of PTHrP, leading to elevated calcium levels that manifest with symptoms such as fatigue, muscle weakness, and bone pain .</li><li>\u27a4 Squamous cell carcinoma of the lung</li><li>\u27a4 paraneoplastic hypercalcemia,</li><li>\u27a4 secretion of PTHrP,</li><li>\u27a4 elevated calcium levels</li><li>\u27a4 fatigue, muscle weakness, and bone pain</li><li>\u27a4 Ref : Robbins and Cotran pathologic basis of disease 10th edition page: 329</li><li>\u27a4 Ref</li><li>\u27a4 : Robbins and Cotran pathologic basis of disease 10th edition page: 329</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "afdcb29f",
      "audio": ""
    },
    {
      "text": "A 60-year-old patient notices spontaneously appearing and disappearing painful, linearly arranged nodules in different parts of the body. Which of the following malignancies is not associated with this clinical presentation?",
      "options": [
        {
          "label": "A",
          "text": "Uterine carcinoma",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pancreatic carcinoma",
          "correct": false
        },
        {
          "label": "C",
          "text": "Bronchogenic carcinoma",
          "correct": false
        },
        {
          "label": "D",
          "text": "Bladder carcinoma",
          "correct": true
        }
      ],
      "correct_answer": "D. Bladder carcinoma",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Bladder carcinoma</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Uterine carcinoma: Uterine carcinoma, particularly when adenocarcinoma , can be associated with Trousseau syndrome due to its propensity to induce a hypercoagulable state , leading to venous thromboembolism.</li><li>\u2022 Option A. Uterine carcinoma:</li><li>\u2022 adenocarcinoma</li><li>\u2022 Trousseau syndrome</li><li>\u2022 propensity to induce a hypercoagulable state</li><li>\u2022 venous thromboembolism.</li><li>\u2022 Option B. Pancreatic carcinoma: Pancreatic carcinoma is strongly associated with Trousseau syndrome . The tumor's release of mucins and procoagulant substances can trigger a hypercoagulable state .</li><li>\u2022 Option B. Pancreatic carcinoma:</li><li>\u2022 Pancreatic carcinoma</li><li>\u2022 Trousseau syndrome</li><li>\u2022 mucins and procoagulant substances</li><li>\u2022 hypercoagulable state</li><li>\u2022 Option C. Bronchogenic carcinoma: Bronchogenic carcinoma, especially adenocarcinoma subtype, is known to produce substances that activate the coagulation system, thus it can be associated with Trousseau syndrome.</li><li>\u2022 Option C. Bronchogenic carcinoma:</li><li>\u2022 adenocarcinoma subtype,</li><li>\u2022 activate the coagulation system,</li><li>\u2022 Trousseau syndrome.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Bladder carcinoma is not commonly associated with Trousseau syndrome , which is characterized by migratory thrombophlebitis and is often seen with deep-seated adenocarcinomas like those of the pancreas, lung, and other visceral organs.</li><li>\u27a4 Bladder carcinoma</li><li>\u27a4 not</li><li>\u27a4 Trousseau syndrome</li><li>\u27a4 migratory thrombophlebitis</li><li>\u27a4 deep-seated adenocarcinomas</li><li>\u27a4 pancreas, lung, and other visceral organs.</li><li>\u27a4 Ref : Robbins and Cotran pathologic basis of disease 10th edition page: 329</li><li>\u27a4 Ref</li><li>\u27a4 : Robbins and Cotran pathologic basis of disease 10th edition page: 329</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b28a414e",
      "audio": ""
    },
    {
      "text": "Which of the following are oncofetal antigens? Alpha-fetoprotein Carcinoembryonic antigen Human chorionic gonadotropin Placental alkaline phosphatase Immunoglobulins",
      "options": [
        {
          "label": "A",
          "text": "1 and 3",
          "correct": false
        },
        {
          "label": "B",
          "text": "1, 3 and 4",
          "correct": false
        },
        {
          "label": "C",
          "text": "3, 4 and 5",
          "correct": false
        },
        {
          "label": "D",
          "text": "1 and 2",
          "correct": true
        }
      ],
      "correct_answer": "D. 1 and 2",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) 1 and 2</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Alpha-fetoprotein (AFP) and carcinoembryonic antigen (CEA) are oncofetal antigens.</li><li>\u2022 Alpha-fetoprotein (AFP) and carcinoembryonic antigen (CEA) are oncofetal antigens.</li><li>\u2022 Alpha-fetoprotein is a valuable clinical aid in diagnosis, prognosis, and monitoring of the following tumors:</li><li>\u2022 Alpha-fetoprotein</li><li>\u2022 diagnosis, prognosis, and monitoring of the following tumors:</li><li>\u2022 Primary hepatocellular carcinoma Hepatoblastoma Non-seminomatous testicular germ cell tumors Embryonal carcinoma Teratomas Choriocarcinoma</li><li>\u2022 Primary hepatocellular carcinoma</li><li>\u2022 Hepatoblastoma</li><li>\u2022 Non-seminomatous testicular germ cell tumors</li><li>\u2022 Embryonal carcinoma</li><li>\u2022 Teratomas</li><li>\u2022 Choriocarcinoma</li><li>\u2022 Carcinoembryonic antigen is normally detected in the glycocalyx of fetal epithelial cells . It is useful in detection, assessing recurrence, and prognosis of the following tumors:</li><li>\u2022 Carcinoembryonic antigen</li><li>\u2022 glycocalyx of fetal epithelial cells</li><li>\u2022 detection, assessing recurrence, and prognosis</li><li>\u2022 Adenocarcinoma of lung Colorectal carcinoma</li><li>\u2022 Adenocarcinoma of lung</li><li>\u2022 Colorectal carcinoma</li><li>\u2022 CEA levels >5 g/dL are noted in ascitic fluid associated with malignancy.</li><li>\u2022 CEA levels >5 g/dL</li><li>\u2022 ascitic fluid</li><li>\u2022 malignancy.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Alpha-fetoprotein and carcinoembryonic antigen are oncofetal antigens , which are expressed during fetal development and re-expressed in certain malignancies, aiding in the diagnosis, prognosis, and monitoring of these cancers.</li><li>\u27a4 Alpha-fetoprotein and carcinoembryonic antigen</li><li>\u27a4 oncofetal antigens</li><li>\u27a4 fetal development and re-expressed</li><li>\u27a4 malignancies,</li><li>\u27a4 diagnosis, prognosis, and monitoring of these cancers.</li><li>\u27a4 Ref : Robbins and Cotran pathologic basis of disease 10th edition page: 336</li><li>\u27a4 Ref</li><li>\u27a4 : Robbins and Cotran pathologic basis of disease 10th edition page: 336</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6f823be8",
      "audio": ""
    },
    {
      "text": "A patient is diagnosed with a malignancy that is associated with an overexpression of the c-Myc gene. Which of the following is the most likely mechanism of this overexpression?",
      "options": [
        {
          "label": "A",
          "text": "Gene amplification",
          "correct": true
        },
        {
          "label": "B",
          "text": "Chromosomal translocation",
          "correct": false
        },
        {
          "label": "C",
          "text": "Point mutation",
          "correct": false
        },
        {
          "label": "D",
          "text": "Gene deletion",
          "correct": false
        }
      ],
      "correct_answer": "A. Gene amplification",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Gene amplification</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Chromosomal translocation: While chromosomal translocations can result in c-Myc overexpression , such as the translocation seen in Burkitt lymphoma (t(8;14), it is less common than gene amplification for the overexpression of c-Myc in a broader range of malignancies.</li><li>\u2022 Option B. Chromosomal translocation:</li><li>\u2022 c-Myc overexpression</li><li>\u2022 translocation seen in Burkitt lymphoma (t(8;14),</li><li>\u2022 overexpression of c-Myc</li><li>\u2022 Option C. Point mutation: Point mutations can activate oncogenes or inactivate tumor suppressor genes, but they are not typically associated with the overexpression of c-Myc. Instead , they might alter the function of the resulting protein.</li><li>\u2022 Option C. Point mutation:</li><li>\u2022 activate oncogenes</li><li>\u2022 inactivate tumor suppressor genes,</li><li>\u2022 overexpression of c-Myc. Instead</li><li>\u2022 Option D. Gene deletion: Gene deletion generally leads to a loss of gene function and is more commonly associated with tumor suppressor genes rather than proto-oncogenes like c-Myc. Deletion would not result in overexpression but rather in reduced expression or loss of function.</li><li>\u2022 Option D. Gene deletion:</li><li>\u2022 loss of gene function</li><li>\u2022 tumor suppressor genes</li><li>\u2022 proto-oncogenes like c-Myc. Deletion would not</li><li>\u2022 overexpression</li><li>\u2022 loss of function.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Gene amplification is a common mechanism for overexpression of the c-Myc gene in various malignancies, leading to increased cell growth and proliferation due to the extra copies of the gene being transcribed.</li><li>\u27a4 Gene amplification</li><li>\u27a4 overexpression of the c-Myc gene</li><li>\u27a4 increased cell</li><li>\u27a4 growth and proliferation</li><li>\u27a4 extra copies of the gene</li><li>\u27a4 transcribed.</li><li>\u27a4 The C-myc gene is a proto-oncogene that codes for a transcription factor involved in cell proliferation and differentiation . Overexpression of c-Myc is seen in many malignancies, and it is often due to gene amplification, which results in an increased number of copies of the gene . Chromosomal translocations can also lead to c-Myc overexpression, but they are less common.</li><li>\u27a4 The C-myc gene is a proto-oncogene that codes for a transcription factor involved in cell proliferation and differentiation . Overexpression of c-Myc is seen in many malignancies, and it is often due to gene amplification, which results in an increased number of copies of the gene .</li><li>\u27a4 C-myc gene is a proto-oncogene</li><li>\u27a4 transcription factor</li><li>\u27a4 cell proliferation and differentiation</li><li>\u27a4 Overexpression of c-Myc</li><li>\u27a4 gene amplification,</li><li>\u27a4 increased number of copies of the gene</li><li>\u27a4 Chromosomal translocations can also lead to c-Myc overexpression, but they are less common.</li><li>\u27a4 Chromosomal translocations</li><li>\u27a4 lead to c-Myc overexpression,</li><li>\u27a4 less common.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a7c260c1",
      "audio": ""
    }
  ]
}